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Abstract
The phosphorylation of proteins, catalysed by protein kinases, play an
important role in nearly every aspect of cell life. The abnormal phosphorylation of
proteins is responsible for the onset of several diseases and disorders including
various types of cancers, diabetes, Alzheimer’s disease, etc. Therefore, the
discovery of protein kinase inhibitors is a major focus of the pharmaceutical
companies. Drug discovery today is dominated by number a of processes that
require expensive chemicals, fluorescent tags and radio-labelling and can often be
time consuming and laborious. Through this research, a new process for the
screening of protein kinase inhibitors has been explored. In order to improve the
cost effectiveness and efficiency of the process, biosensors have been developed
using printed circuit board (PCB) technology and made compatible with
commercially available complementary metal oxide semiconductors (CMOS).
Designing a REFET structure for biosensing where the reference electrode can be
eliminated was the final aim.
In this thesis, the techniques which are already in use are reviewed in order
to understand their drawbacks and to help improve our design. A sensor array that
can fit under the industrially used 96 well microtitre plate has been designed such
that the existing techniques of liquid handling for drug discovery can be used.
In the first technique an electrolyte-insulator-semiconductor structure is
interfaced with a PCB for sensing pH changes associated with phosphorylation,
through capacitance versus voltage measurements. Next, organic thin film
transistors with gold extended gates have been used to detect charge changes
during a phosphorylation reaction. Thin films of evaporated tin oxide and
tantalum oxide on a PCB have also been tested as pH sensitive membranes for this
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reaction. The thin films have been used as extended gates for commercial CMOS
circuits and the shift in their drain current versus gate voltage characteristics have
been measured.
The REFET structure has been finally designed with tin oxide as the
sensing layer. The reference layer has been designed using a thin film made of
SU-8 photoresist as a pH insensitive layer. The two thin films have been used as
extended gates to a commercially available matched pair CMOS integrated circuit
and a differential measurement in their drain current for a fixed gate voltage is
conducted for the phosphorylation reaction. Finally, array of REFET structures
are multiplexed for the possibility of high throughput screening. The final device
provides an excellent starting point for fabricating sensor arrays compatible with
the widely accepted well plate structure and associated liquid handling systems.
Keywords: biosensor, REFET, high throughput screening, PCB based
biosensor
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Over the years, advances in chemistry and chemical engineering have
made it possible to rapidly and efficiently synthesise a large number of novel
compounds which have the potential to be therapeutic drugs. This has led to the
development of several high throughput screening (HTS) techniques to
economically and quickly eliminate compounds and identify hits1. The advances in
high throughput screening technologies over the last decade have led to the
incorporation of automatic sample delivery systems and specialised software. As a
consequence, it is now possible to screen over 10,000 compounds daily. Today, high
throughput screening has been adopted by the pharmaceutical industry as well as
academia as the standard technique for drug discovery [1].
The high cost associated with bringing a new drug to market is resulting in
a number of productivity challenges for the pharmaceutical companies. New drugs
undergo several stages of assessment such as clinical trials and pre-clinical trials.
The use of high throughput screening techniques has successfully shown to reduce
the cost of drug development [2]. The effectiveness of high throughput screening
comes from the fact that drugs are screened with a focus on a single mechanism.
The use of an array of microreaction wells in the form of a microtitre plate (96
1The compound that displays the desired characteristics of the drug is known as a hit
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wells or more) has gained popularity in the field of HTS drug discovery. Figure
1.1 shows a typical 96 well plate used for drug discovery. A library of molecules is
usually tested for binding or biological activity against one or more targets using
these microtitre plates [1].
Figure 1.1: High Throughput Screening Using Microtitre Plates [Image Source:
http://www.ddw-online.com]
Protein phosphorylation is a reversible process catalysed by enzymes
called protein kinases where a phosphate group is transferred from a phosphoryl
donor like adenosine triphosphate (ATP) to certain amino acid residues. The
extensive study of protein phosphorylation, since it was first discovered in 1954,
has led to the understanding of its cardinal role in almost all aspects of cell life.
So, abnormal phosphorylation of proteins is responsible for a number of diseases
and disorders ranging from neurodegenerative diseases, inflammatory diseases,
various types of cancers, cardiovascular disorders, diabetes, infectious diseases, etc
[3] [4] [5]. Therefore, it is not surprising that protein kinases which regulate the
phosphorylation process are major drug targets of the twenty first century [6].
Protein kinase inhibitors take up a major share of research and development
in pharmaceutical companies. Almost 50-70% of cancer drug discovery initiatives
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are centred around protein kinase inhibitors [4].
There are numerous assays commercially available for the drug discovery
of kinase inhibitors. The traditional methods such as western blot are laborious,
time consuming and not suitable for HTS. The existing HTS technologies also suffer
from major drawbacks such as the need for labelling biomolecules with radio isotopes
(radio-labelling) and the presence of specific antibodies. The processes are labour
intensive and contain repeated washing steps. The radioactive materials pose a
safety risk and hence their disposal requires special techniques and precautions.
The reagents used in the studies are expensive and add to the overall cost of drug
development.
This research project attempts to improve the process of high throughput
screening of kinase inhibitors by developing a cost effective, label free alternative
to existing techniques using field effect devices. An interface is made between the
sensors and commercial complementary metal oxide semiconductor (CMOS)
integrated circuits (ICs) to make this screening technique more cost effective than
designing a monolithic integrated circuit.
1.2 Background
Biosensors are analytical devices that can convert a biological response
into a measurable electrical signal [7]. The basic concept of a biosensor was first
reported by pioneers Clark and Lyons in 1962 with the ’enzyme electrode’ [8].
Since then, the field of biosensors has developed rapidly with applications in food,
pharmaceuticals, healthcare, defence and environmental monitoring to name a few
[9]. The commercial biosensors that dominate the market are in the healthcare
sector and medical diagnostics with an estimated market value of over 13 billion
US dollars [10].
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Rapid progress in solid state technologies has led to the emergence of field
effect transistor (FET) based biosensors. Biomolecules often carry electrostatic
charges and biochemical activities result in changes in electrical potential which
can be utilised in field effect based sensors. The complementary metal oxide
semiconductor (CMOS) manufacturing process is widely accepted and has
facilitated the development of miniaturised sensor arrays which can be integrated
with electronic circuits and instrumentation [11].
FET based biosensors are similar to Metal Oxide Semiconductor Field
Effect Transistors (MOSFETs) where the metal gate has been replaced by an
electrolyte. The change in potential at the gate terminal induces band bending of
the semiconductor channel due to the electric field and the carrier concentration
changes. The potential at the gate can be is influenced by the solution potentials
such as pH and presence of charged biomolecules. The current voltage
characteristics are shifted positively or negatively as a result [11].
Since the discovery of the ion sensitive field effect transistor (ISFET) in
1970 by P. Bergveld [12], FET based biosensors have made significant progress.
ISFETs fabricated through the unmodified CMOS process have proved to be very
successful in designing pH sensitive sensor arrays [13, 14]. The advantages of this
process are the scalability, low power operation and the ability to use the passivation
layer as the pH sensitive layer. There are some drawbacks to this process. Use of the
passivation layer causes a variation in threshold voltage between individual sensors
due to the presence of trapped charges [15].
Another widely used field effect based biosensor is the extended gate
FET. The sensing structure connected to the gate extends off the chip and allows
the separation of wet and dry environments. The biochemical modifications and
exposure to the analyte in solution can be performed on the extended gate
independent of the transducer [16]. This structure has been used for a number of
studies like pH sensing [17], DNA sensing [18] and enzyme sensing for cholesterol
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detection to name a few [19].
Electrolyte-insulator-semiconductor (EIS) structures are another type of
field effect device. They are often preferred for being easier to fabricate than ISFETs
or EGFETs [20]. Several pH sensors [21] [22] and biosensors, such as glucose sensors,
based on EIS structures [23] have been reported in literature.
Other structures like dual-gate FET sensors and floating gate sensors have
been reported in literature. Floating gate structures have two gates where one gate
serves as the control gate and the other as a sensing gate. They are both capacitively
coupled to the floating gate. The principle of detection is usually dependant on
the charged molecule under study inducing a change in the threshold voltage which
allows for the elimination of the reference electrode [24]. Biosensors like DNA sensors
using this structure have been reported [25]. Some studies have reported significant
instabilities due to the gate being at a floating potential [26]. Dual-gate FETs are
similar except that they employ an addition back gate for an increased slope in the
sensor response [26]. This has been used for DNA and pH detection, among other
studies [27] [28].
1.3 Aim
Field effect biosensors are very promising candidates for biosensing
applications. They are easy to fabricate and interface with low cost commercially
available electronic components. In this thesis, different field effect structures will
be assessed as potential biosensors for screening protein kinase inhibitors. The
overall aim is to design a sensor array consisting of field effect devices that can be
multiplexed for measurement. The sensor array will be designed such that its
dimensions and spacing are according to the layout of the 96 well microtitre plate.
Although having a sensor compatible with a 96 well plate is not strictly essential, a
system compatible with a widely accepted component of HTS will make
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assessment of the device by end-users easier. In future applications, it would be
desirable to move towards a miniaturised system.
For ease of fabrication and reduction of cost, an FR4 substrate is chosen
for most of the studies in this thesis. The final aim is to eliminate the reference
electrode and instead use a differential measurement between a ’sensitive’ and an
’insensitive’ biosensor. The research problems that will be explored in study are as
follows:
1. Suitable pH sensitive material for detection of pH changes due to
phosphorylation
2. Suitable field effect device for forming an array of sensors on a printed circuit
board (PCB)
3. A device configuration that permits the elimination of the reference electrode
4. A sensor array compatible with commercially available integrated circuits for
measurement
1.4 Overview of the Thesis
This thesis details the process of development of a field effect based
biosensor for screening protein kinase inhibitors. The biosensor ideally will be
compatible with a 96 well microtitre plate so that existing processes of solution
handling can be used in the future.
Chapter 2: This chapter explores the existing techniques for the screening
of protein kinase inhibitors. The drawbacks of these techniques are highlighted to
establish the need for a new and improved system. The drawbacks are addressed
in our device design in the later chapters. The importance of the phosphorylation
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reaction and its role in major diseases is also described. Finally, the background of
the field effect devices used in this research is presented.
Chapter 3: Initial attempts to select a suitable field effect based device for
this research is described in this chapter. Electrolyte-Insulator-Semiconductor (EIS)
structures made from Si3N4 coated silicon wafers mounted on printed circuit board
(PCB) is tested for its pH sensitivity and used to detect protein phosphorylation.
In the second part of this chapter, organic thin film transistors with extended gates
are assessed for their suitability for this application.
Chapter 4: Tin oxide as a pH sensitive sensing layer for protein
phosphorylation is explored in the first part of this chapter. The layer is deposited
directly on to the PCB. pH sensitivity and phosphorylation studies are performed
in this study. Tantalum oxide is briefly studied in view to replace tin oxide. In the
second part of this chapter, attempts to fabricate a pH insensitive device that can
act as a ’reference’ measurement is described. The thin films in this study are
tested for their lack of sensitivity to pH and the phosphorylation reaction.
Chapter 5: In this chapter the attempts to interface the biosensors in
chapter 4 with commercial CMOS integrated circuits is described. A device
consisting of the sensing layer and the reference layer are used for differential
measurements to detect protein phosphorylation. The sensors are multiplexed
using commercial low cost integrated circuits and the data is collected through an
Arduino.
Chapter 6: Overall conclusions and future outlook is addressed in this
chapter.




2.1 Importance of Protein Phosphorylation
The phosphorylation of proteins plays a significant role in regulating
cellular events. Protein phosphorylation is a reversible process catalysed by
enzymes called kinases whereby phosphate groups from a phosphate donor like
Adenosine Triphosphate (ATP) are attached to specific amino acid residues post
translation1. The reverse process or dephosphorylation is catalysed by a class of
enzymes known as phosphatases. In eukaryotic cells, phosphorylation mainly
occurs on serine, threonine and tyrosine residues [29]. Phosphorylation is of
cardinal importance in regulating processes like cell growth, apoptosis,
proliferation and differentiation [30]. The abnormal phosphorylation of proteins is
the cause of several human diseases. The mutation of protein kinases and
phosphatases results in diseases like Parkinson’s disease, muscular dystrophy, viral
infections, cardiovascular diseases and various types of cancers [31] [3]. Figure 2.1
illustrates the reversible protein phosphorylation process.
The activity of protein kinase was first discovered in 1954 by Gene Kennedy
who observed the phosphorylation of casein by a liver enzyme [32]. Fischer and
Krebs [33] [34] along with Wosilait and Sutherland [35] described the mechanism
1The process by which proteins are created by the ribosomes present in the cells is known as
translation
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Figure 2.1: Reversible Protein Phosphorylation (Pi symbolises a hydrolysed
phosphate group)
of phosphorylation and dephosphorylation that occurs during the interconversion
of phosphorylase b to phosphorylase a in the presence of Mg-ATP and an enzyme.
This is when the termed phosphorylase kinase was coined. The work done by Fischer
and Krebs earned the Nobel prize in 1992. A number of diseases that result from
abnormal protein phosphorylation are listed in Table 2.1.
Table 2.1: Some Diseases Caused by Abnormal Protein
Phosphorylation [3]
Disease Kinase/Phosphatase
Myotonic muscular dystrophy Myotonin protein kinase
X-Linked agammaglobulinaemia Bruton tyrosine kinase
Hirschsprunǵıs disease Ret2 kinase
Autosomal recessive SCID Zap70 kinase
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Disease Kinase/Phosphatase
X-Linked SCID Jak3 kinase
Chraniosynostosis FGF receptor kinase
Papillary renal cancer Met receptor kinase
Chronic myelomonocytic leukaemia Tel-PDGF receptor kinase
Chronic myelogenous leukaemia Abelson tyrosine kinase
Non-Hodgkins lymphoma Alk kinase
Peutz–Jeghers syndrome Lkb1 kinase
Coffin–Lowry syndrome MAPKAP-K1b (RSK-2)
Ataxia-telangiectasia Atm kinase
Li–Fraumeni syndrome Chk2 kinase
Williams syndrome Lim kinase-1
Leprechaunism, diabetes Insulin receptor kinase
Wolff–Parkinson–White syndrome AMP activated kinase
Wolcott–Rallison syndrome eIF2A-kinase 3
X-Linked myotubular myopathy MTM1 Tyr phosphatase
2.2 Protein Kinase Inhibitors
It took several years, since their discovery in 1955, before the importance of
protein kinases was appreciated. Today mutations in protein kinases are known to
result in abnormal phosphorylation and lead to a number of diseases. Protein kinase
inhibitors emerged as an important class of drugs that targeted the ATP binding
pockets of the enzyme. Figure 2.2 shows the Web of Science citation reports for
the keywords ”kinase inhibitor” and ”discovery”. It is evident that research on the
discovery of kinase inhibitors has increased significantly over the years. Based on
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their binding modes, kinase inhibitors may be classified as reversible and irreversible.
In reversible inhibition, the inhibitor covalently binds to the ATP binding pocket to
prevent the binding of ATP while in the case of reversible inhibition the molecule
interacts with kinase in order to prevent access to the ATP binding site [36] [37].
Table 2.2 lists some of the kinase inhibitors from major pharmaceutical companies
which are in advanced clinical trial or have been approved for clinical use.
Figure 2.2: Web of Science citation reports for ”kinase inhibitor” and ”discovery”
search terms. (A) Publications per year (B) Citations per year (Data collected in
February 2019)
Table 2.2: Protein Kinase Inhibitors from Major Pharma
Companies which are in Advance Clinical Trial or
Approved for Clinical Use: From the Blue Ridge Institute
for Medical Research in Horse Shoe, North Carolina USA
[4]
Name Company Approval
Eril-Fasudil Eisai 1995 cerebral vasospasm
Rapamune-
Sirolimus
Wyeth Pfizer 1999 kidney transplantation
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Name Company Approval
Imatinib Novartis 2001 chronic myelogenous leukemia
Gefitinib Astra Zeneca 2003 lung cancer
Erlotinib Genetech Roche 2005 lung, pancreatic and others cancers
Sorafenib Onyx Bayer 2005 renal cancer
Nilotinib Novartis 2007 chronic myelogenous leukemia
Temsirolimus Wyeth Pfizer 2007 advanced renal cell carcinoma




Ruxolitinib Incyte 2011 myelofibrosis
Crizotinib Pfizer 2011 NSCLC with Alk mutation
Vemurafenib Roche 2011 melanoma
Vandetanib Astra Zeneca 2011 thyroid cancer
Axitinib Pfizer 2012 renal cell carcinoma
Bosutinib Pfizer 2012 chronic myelogenous leukemia
Tofacitinib Pfizer 2012 rheumatoid arthritis
Regorafenib Stivarga Bayer 2012 colorectal cancer, GIST
Cabozantinib Cometriq
Exelixis Inc
2012 medullary thyroid cancer







Ceritinib Novartis 2014 NSCLC
Nintedanib Boehringer
Ingelheim
2014 idiopathic pulmonary fibrosis
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Name Company Approval
Alectinib Roche, Chugai 2014 Alk-rearranged NSCLC
Palbociclib Pfizer 2015 advanced (metastatic) BC
Cobimetinib Roche, Exelixis 2015 melanoma
Osimertinib Astra Zeneca 2015 NSCLC with EGFR mutation
Abemaciclib Lilly 2017 Breast Cancer
Midostaurin Novartis 2017 Acute myeloid leukemia,
mastocytosis, mast cell leukemia
Acalabrutinib Acerta Pharma 2018 Mantle cell lymphoma
Baricitinib Lilly 2018 Reumatoid arthritis
Binimetinib Array 2018 Melanoma
Dacomitinib Pfizer 2018 EGFR-mutant NSCLC
Encorafenib Array 2018 Melanoma
2.3 Screening Process for Protein Kinase
Inhibitors: Traditional Methods
2.3.1 Western Blot
The most commonly used assay for detecting the phosphorylation state of a
protein is western blot. The proteins are first separated using SDS- PAGE2 and then
transferred to a polyvinylidene difluoride or nitrocellulose membrane. A phospho-
specific antibody is employed to identify the protein. Many of the antibodies are
quite sensitive and can easily detect the phosphorylated protein. Commonly used
2Separation of proteins by electrophoresis utilizes a discontinuous polyacrylamide gel as a
support medium and sodium dodecyl sulfate (SDS) to denature the proteins. This method is
called sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
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detection methods use the princliples of chemiluminescence or colorimetry. [38] [39].
Major Drawbacks:
1. This is a time consuming and labour intensive process
2. It requires optimisation of experimental conditions like separation process,
buffers, etc
3. Antibodies are required for this technique, which are expensive and
non-sustainable
4. Not suitable for high throughput screening
2.3.2 Mass Spectrometry
Mass spectrometry is a two-step process. The protein under study is first
proteolytically digested3 with the protease trypsin. The peptide chains are then
investigated for phophorylation. The phosphorylated peptides are further studied
using tandem mass spectrometry (MS/MS) to locate the phosphorylation sites. The
phosphorylated peptides can be identified by comparing their masses to the list of
expected peptide masses for mass increases of 80 Da, which is the mass of the
phosphate group [40] [41] [42].
Major Drawbacks:
1. The signals from less abundant phosphorylated peptides may be lost amongst
the more abundant non-phosphorylated peptides.
2. Peptide fragmentation and improper sample preparation may lead to
decomposition of phosphate groups on the protein.
3The breakdown of proteins into smaller peptide chains and amino acids, catalysed by proteases
is known as proteolytic digestion
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2.3.3 Filtration Binding Assay
In this assay, the protein phosphorylation reaction is conducted by utilising
radio-labelled [γ-33P]ATP or [γ-32P]ATP. The phosphorylation reaction is followed
by binding of the radio labeled products to filters. The unreacted phosphate is
washed away. This method is universal and can be used for any kinase and substrate
without limitations. Labelling or modification of the substrate is not required and
detection is independent of interference from the unreacted radioisotope [43].
Major Drawbacks:
1. This process requires radioisotopes. The handling of these need special care
and precaution. The disposal of samples also needs to be done with special
considerations.
2. Complex washing steps are labour intensive and time consuming.
2.3.4 Enzyme Linked Immunosorbent Assay (ELISA)
Before being taken over by more advanced techniques, ELISA systems
were very widely used for drug discovery. This assay uses antibodies specific for the
protein used in the test. Microtitre plates coated with antibodies are used to bind
the protein. A separate antibody specific to the detection site to be analysed is
then introduced. Before detection, the chemical compounds are washed away. The
analysis of the phosphorylated proteins is usually by fluorometric or colorimetric
techniques as the antibodies are usually labelled with highly fluorescent dyes. The
intensity of the signal depends on the concentration of phosphorylated protein. The
use of multiwell plates allows higher throughput as compared to other processes like
Western Blot [44] [45] [46].
One of the commercially available ELISA kits is DiscoveryDotTM.
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Major Drawbacks:
1. The need to develop specific antibodies
2. The need for multiple washing steps limits the throughput of the assay
2.4 Screening Process for Protein Kinase
Inhibitors: High Throughput Screening
Though there are different approaches to modulate the activity of protein
kinases, inhibition of the catalytic site of the enzyme with ATP-competitive
inhibitors remains the most promising technique. The process of drug discovery is
initiated by high throughput screening of a large number of molecules [47].
Traditional methods like gel based assays, ELISAs and filter binding assays are not
useful in screening a large number of molecules because they are time consuming
and require postreaction steps.
In order to screen kinases, the pharmaceutical industry makes a choice
between cellular based assays and biochemical assays. Cell based assays suffer
from a major disadvantage where a number of ‘off-target hits’ or false hits are
produced due to inhibition of activities other than the one being studied as
number of targets are unintentionally being screened. This complicates the process
by introducing the need for further analysis after the screening. Therefore,
biochemical assays are preferred as a mode of screening inhibitors. Not only is it
possible to fix the targets during the assay but a higher concentration of the
chemical under test can be used [48]. Fluorescence based assays have been adopted
for high throughput screening where the optical readout signal is generated by
scintillation, chemiluminescence and electrochemiluminescence [49]. Some of the
fluorescence based assays used industrially are Scintillation Proximity Assay,
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Fluorescence Resonance Energy Transfer, Fluorescence Polarization and Amplified
Luminescence Proximity Homogeneous Assay.
2.4.1 Scintillation Proximity Assay (SPA)
The transfer of the 32P from [γ-32P]ATP to a synthetic peptide or protein
causes the peptide or protein to be labelled with 32P. These can be captured on a
filter and washed in order to separate them from ATP. The phosphorylated proteins
or peptides now emits beta particles due to radioactive decay and can be measured
by a scintillation counter [50]. The use of 33P instead of 32P allows the elimination of
the washing step as separation can be done using scintillation crystals functionalized
with streptavidin to which biotinylated peptides bind. The decay of the radioactive
33P in close proximity to the scintillation crystal is what generates the signal for
measurement [51].
GE’s LeadSeekerTM is one of the commercially avialable SPAs.
PerkinElmer’s Flashplate R© and Scintiplates R© also provide this assay using
microtitre plates coated with scintillation material [43].
Major Drawbacks:
1. The safety considerations while handling radioactive materials
2. The cost of disposing of the radioactive waste materials
3. False signals due to radioactive decay of [γ-32P]ATP [52]
2.4.2 Fluorescence Resonance Energy Transfer (FRET)
FRET based screening techniques make use of an autofluorescent protein
(AFP) couple or antibodies labelled with fluorophores, separated by a substrate
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sequence and a linker. The AFP couple is capable of energy transfer between the
donor and acceptor fluorophore [53]. When the substrate sequence is
phosphorylated, the linker causes a conformational change of the sensor as a result
of which the AFP pairs are brought together. The fluorescence resonance energy
transfer between the pair of AFPs causes the donor AFP to lose fluorescence
intensity and lifetime while the acceptor AFP gains in fluorescent intensity and
lifetime [31] [54].
A commercially available FRET based assay is Z-LyteTM developed by
Invitrogen [43].
Major Drawbacks: The need for specific antibodies is a major drawback
of this approach.
2.4.3 Fluorescence Polarization (FP):
Fluorescence polarization assay is based on the principle that a heavier
molecule, when excited with polarized light, will rotate more slowly compared to
a lighter molecule. Polarization can be measured when a fluorescent molecule is
excited with polarized light. The assay uses anti-phosphopetide antibodies and
fluorescence tagged peptides. The phosphorylation of the peptides during the assay
results in an increase in binding to the antibodies. The fluorophore on the antibody
can now rotate more slowly, which causes the polarization of the light to change [55]
[56].
There are a number of commercially available assay kits using fluorescence
polarization. BellBrook’s TranscreenerTM FP assay, DiscoveRx’s HitHunterTM FP
assay and Millipore’s KinEASETM are a few of them [43].
Major Drawbacks:
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1. Antibodies required for this assay
2. Generation of false signals due to the interference from fluorescent tagging
molecules and other coloured or fluorescent compounds [57] [58].
2.4.4 Amplified Luminescence Proximity Homogeneous
Assay (ALPHA)
This assay utilizes two reagent coated polystyrene microbeads, a donor
and an acceptor, of 250 nm diameter. The microbeads coated with
anti-phosphotyrosine and anti-peptide antibodies come into proximity by a
biomolecular interaction. Next, assay mixture, with the donor bead containing a
photosensitizer, is irradiated with a high intensity laser at 680 nm which causes the
ambient oxygen to convert to an excited singlet state. The singlet oxygen can react
with the thioxene derivative present in the acceptor bead if it is in the proximity
and can generating chemiluminescence. The chemiluminescenese can stimulate the
fluorophores present on the acceptor bead. The detection wavelength is shorter
than the excitation wavelength which reduces the chances of interference [59] [60].
A commercially available assay is PerkinElmer’s ALPHAScreenTM [43].
Major Drawbacks:
1. Antibodies required for this assay
2. Generation of false signals due to the interference from fluorophors [49].




Capacitive EIS structures are attractive candidates when it comes to
fabrication of multiplexed electronic sensors. The main reason for their widespread
use is the fact that they provide the possibility of on-chip integration to yield
sensor arrays. The speed of response coupled with the ease of fabrication allows
them to be applied as sensors in a number of different fields [61]. Figure 2.3 shows
the schematic of a typical EIS structure.
Figure 2.3: Schematic of EIS Structures
The sensor design consists of a silicon substrate (p-type or n-type) which
is separated from the electrolyte by an insulator layer. A ’binding’ or sensing layer
is present on top of the silicon substrate. The mechanism of charge detection is that
the presence of the biomolecule exerts an electric field on the substrate and modifies
its space charge or depletion region. The presence of immobilized ions acts as an
added dielectric along with the insulator. The overall capacitance of the structure is
the sum of series capacitance of silicon dioxide and the depletion layer capacitance.
The oxide layer capacitance being constant, the total capacitance depends on the
depletion layer [62].
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The charges from solution accumulate on top of the insulator layer. The
ions that accumulate between the electrolyte and charges on the active surface form
an electrical double layer close to the surface [63].
When silicon nitride layer is used as an insulator, the exchange of H+ ions
between the solution and the binding sites on the Si3N4 surface determines the
surface potential. The silanol (SiOH) and the primary amine SiNH2 groups are the
two binding sites on silicon nitride which undergo the following reactions to generate
a surface potential [64] [65]:
SiOH←−→ SiO– + H+
SiOH + H+ −−→ SiOH2+
SiNH2 + H
+ −−→ SiNH3+
Change in the surface charge occurs due to change in the pH of the
electrolyte. The typical capacitance versus voltage characteristics of an EIS
structure with p-type silicon substrate (using a varying dc voltage superimposed
on a small ac signal) is shown in Figure 2.4. When a negative voltage is applied,
the holes from the bulk silicon are attracted to the semiconductor-insulator
interface where they accumulate. In the accumulation region, the EIS capacitor
behaves like a conventional parallel plate capacitor and the total capacitance is the
measure of the capacitance of the insulator layer (Ci). This is also the maximum
capacitance of the system (Cmax).
When a small positive voltage is applied, the holes are repelled from the
same interface resulting in a region depleted of majority charge carriers. The total
capacitance is now represented as the series combination of Ci and the varying
capacitance of the depletion region. At higher values of positive voltages, the
electron concentration at the interface exceeds the hole concentration and the
device begins to behave like an n-type semiconductor. If the frequency of the signal
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is high (1000 Hz or more), the generation of the charge carriers is not fast enough
to attain equilibrium. Hence, the change is not reflected in the C-V curve [66]. The
device contains some electrically active defects located at the interface between the
insulator and the semiconductor which is capable of trapping and de-trapping
charge carriers. These are known as interface traps. At high frequencies (100Hz or
more), the effect of these traps is dampened. The time required to generate a
trapped charge response is longer than an untrapped charge carrier. At low
frequencies, the interface traps are able to follow the oscillations and contribute to
the excess capacitance seen at the output. This is the reason why high frequencies
are preferred during the capacitance-voltage measurements [62] [67].
Figure 2.4: Capacitance versus voltage curves for EIS structures with p-type
semiconductor
EIS sensors have been used extensively for the detection of biomolecules
like DNA [68] [69], enzyme reactions [70] [71] and other charged macromolecules
[72]. Miniaturised pH sensors integrated within flow cells have also been reported
in literature [73]. In 2014, Bhalla and co-workers reported the detection of protein
phosphorylation by detecting the changes in pH due to release of protons during
the process, using EIS structures. For the phosphorylation of Myelin Basic Protein
(MBP), a change in surface of +3.3 C was observed which results in a local pH
change from 7.2 to 8.8. As a consequence of this, the threshold potential of the EIS
structures (n-type silicon substrate) changed by 37 mV as compared to the control.
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A pH sensitivity of 51.7 mV/pH was achieved in this study. [74].
2.6 Ion Sensitive Field Effect Transistors (ISFET)
as Biosensors
An ISFET can be simply described as a MOSFET where the gate metal
is replaced by an electrolyte which is in direct contact with the gate insulator. The
expression for drain current is the same as the one for MOSFET when it is not in








where Cox is the oxide capacity, µ is the electron mobility in the channel, W/L is
the ratio of width and length of the channel, Vt is the threshold voltage.




and the applied drain to source voltage are constant, the drain current IDS is a
function of the gate to source voltage VGS [75]. The schematic of a typical ISFET
is shown in Figure 2.5.
Figure 2.5: Schematic of an ISFET (VGS and VDS are the gate to source and drain
to source voltages respectively)
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Modifying the gate terminal of the ISFET with ion sensitive materials
like silicon nitride makes it sensitive to pH variations. The binding of charged
biomolecules at the gate terminal is analogous to changing the gate voltage. The
charged molecules result in a change in electric field at the gate, which is responsible
for change in channel conductance of the ISFET. This affects the value of external
gate voltage required to switch the device to its on or off state [76] [77]. Figure
2.6 shows the pH dependent drain current versus gate voltage characteristics of an
n-type ISFET containing silicon nitride at the gate.
Figure 2.6: Change in drain current versus gate voltage for a fixed drain to source
voltage measured at different pHs for an n-type ISFET with silicon nitride at the
gate [78]
ISFETs have been commercialised as pH sensors by several companies.
One example of a commercial ISFET pH sensor is Durafet R© by Honeywell. Over
the years, the surface charge sensitivity of ISFETs have been exploited for a number
of sensors for charged molecules like DNA, RNA, peptides, proteins, enzymes and
cells [77] [79]. In 2007, Freeman and co-workers studied the phosphorylation and
dephosphorylation of a peptide using ISFETs in the presence of a protein kinase
[80].
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2.7 Organic Thin Film Transistors (OTFTs) as
Biosensors
The increasing popularity of OTFTs compared to silicon based field effect
transistors can be attributed to a number of reasons. Conventional silicon
technology requires high temperature high vacuum processes for deposition and
sophisticated photolithography techniques for patterning. OTFTs can be
fabricated using low temperature deposition and solution methods which facilitates
the use of high-throughput manufacturing like spin coating [81] or printing [82].
Organic materials also possess mechanical flexibility which makes them compatible
with flexible substrates such as plastic. This makes them excellent candidates for
low cost, lightweight, foldable products [83].
Figure 2.7: (a) Schematic of a typical organic thin-film transistor and (b) Typical
output curves for an OTFT highlighting the relationship between IDS, VDS and VGS.
[84]
Similar to inorganic FETs, OTFTs consist of three device terminals.
There are three metal electrodes, a dielectric layer and a thin film of organic
semiconductor. The dielectric or insulator layer separates the semiconductor from
the metal gate electrode. [84]. The semiconductor layer may consist of small
molecules like pentacene [85], anacene [86], oligomeres [87] or polymers like
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polythiophenes [88] [89] or carbon nanotubes [90].
The operation of the OTFTs is analogous to inorganic FETs. The current
flow between source and drain can be controlled by the bias applied to the gate
terminal. Unlike inorganic materials, current is carried by majority charge carriers
in organics [83]. Capacitive coupling between the gate electrode and semiconductor
layer induces charges on the semiconductor layer on application of the gate bias [91].
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(Vg − Vt)2 VDS > Vg − Vt
where IDS is the channel current between source and drain, W and L are
the width and length of the channel, respectively, µ is the mobility of the carrier,
Ci is the capacitance of the gate insulator, Vg is the gate voltage, VDS is the applied
source-drain voltage, and Vt is the threshold voltage of the device. The channel
current can be modulated by change in device parameters namely, µ and Vt due to
interaction with the target analyte [93].
Several biosensors such as glucose sensors [94], dopamine sensors [95] and
DNA hybridisation sensors [96] employ OTFT devices for measurement. They can
also be integrated within cells due to their inherent biocompatibility [97].
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2.8 Reference Field Effect Transistors (REFET)
for Biosensing
The REFET configuration (shown in Figure 2.7) involves the design of two
transistors on the same chip. One of them is an ISFET sensitive to ions while the
other is a reference FET desensitized to ions. A metallic pad or strip acts as a
pseudo or quasi reference electrode to ground the measuring solution [98]. The two
FETs should ideally have identical electrical and chemical properties. The metal-
electrolyte interface may generate an unstable potential which when measured by
a differential configuration of the ISFET and REFET does not result in an output
voltage as it is suppressed as a common mode signal. When a change in pH of the
solution occurs, a differential signal will be generated at the output because the
ISFET is sensitive to the change while the REFET is not [99].
Figure 2.8: Block diagram of ISFET/REFET measuring system where the output
voltage is a function of pH changes in the solution
Since the ISFET and REFET are used in a differential configuration
effects due to changes in light, ambient temperature and other sources of noise are
eliminated as common mode signals [75]. Modifying the gate of a MOSFET such
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that it is completely insensitive to pH or any changes in concentration has proved
to be a challenge. The first reported REFET was constructed by coating the
silicon nitride gate of a MOSFET with parylene and showed a pH sensitivity of 10
to 30 mV/pH [100] [101]. Since then a number of applications of REFETs with
varying pH sensitivities have been developed. This configuration is compatible
with the commercial CMOS process which allows the ease of fabrication,
miniaturization, low cost and simple packaging [102] [103] [104].
Several different materials have been used to form the inert layer of the
reference FET. Oxidizing the Si3N4/SiO2 dielectric to SiOxNy/Si3N4/SiO2
showed a pH sensitivity of 18-20 mv/pH [105]. Others have used polymers such as
polypyrrole on tin oxide/indium tin oxide surface [106] and teflon [107]. Low pH
sensitivities have been reported with the use of a thick layer of polyvinyle chloride
(PVC) (pH sensitivity 1.8 mV/pH) [108] and acrylate layers (pH sensitivity less
than 1 mV/pH) [99]
REFETs have been used as sensors for a number of applications other
than simple pH sensors. The detection of urea [109], glycated haemoglobin [110]
and nucleic acid amplification [111] to name a few.
2.9 Field Effect Devices for Detecting Protein
Phosphorylation
A number of studies have utilised field effect devices for the detection of
protein or peptide phosphorylation. The change in charge of the substrate protein
and the release of proton on phosphorylation can be used to detect this reaction.
Freeman et al. in 2007 reported an ISFET based detection system for the activity
of casein kinase II enzyme. The aluminium oxide gate of an ISFET was modified
with a self assembled monolayer of peptide. The shift in transfer characteristics were
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measured on introduction of the enzyme and ATP. A shift of 40 mV was achieved
over 20 minutes. This sensor was made reusable by dephosphorylating the peptide
on introducing an alkaline phosphatase [80].
In a study conducted by Bhalla et al. in 2014, protein phosphorylation
was detected based on proton release phenomena.
Electrolyte-insulator-semiconductor structures made by silicon nitride coated
silicon wafers were modified with myelin basic protein. The shift in capacitance
versus voltage characteristics was 37 mV after 13 minutes of incubation with ATP,
PKC lipid activator and PKC-α kinase. The control signal showed a negligible
shift of 1.9 mV [74]. In another study by the same author, aluminium oxide
extended gates modified with protein was used for phosphorylation detection
through ISFETs. A 44 mV shift in the transfer characteristics was reported after
10 minutes of incubation with ATP, PKC lipid activator and enzyme [112].
Measurement of phosphorylation kinetics on a large array of ISFETs was
patented in 2012 by Lindsay and Labaer. Nucleic Acid Programmable Protein
Arrays (NAPPA) were proposed in combination with ISFET arrays to to enable
very large kinase enzyme activity assays [113].
2.10 Summary of the Literature Review
Protein kinases are major drug targets and the drug discovery of protein
kinase inhibitors is of paramount importance for both industry and academia. The
drug discovery process of protein kinase inhibitors has moved towards high
throughput screening with the ability of screen large libraries of molecules per day
as opposed to the traditional labour intensive and time consuming processes. From
the literature, it can be concluded that the present high throughput assays for
protein kinase inhibitors still rely heavily on the use of radio tags, fluorophores
and/or antibodies and the readouts are predominantly fluorometric. The problems
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associated with assays can be summarized as follows:
1. Traditional methods cannot be used for HTS assays as they are labour
intensive, time consuming and cost inefficient
2. Radio tagging requires safety considerations and proper reagent disposal
infrastructure
3. Use of fluorescent tags, fluorophores and antibodies come with an added cost
4. The readout systems are susceptible to false signals and interference from other
compounds
Field effect devices like EIS structures, ISFETs and OTFTs are excellent
for biosensing technologies that require low cost of production, ease of fabrication
and can be constructed into sensor arrays.
2.11 Objectives of the Project
In this project, the development of a high throughput multiplexed sensor
array for the screening of protein kinase inhibitors is investigated which can address
the drawbacks of the present systems. It is our aim to move towards a low cost,
high throughput, portable sensor for drug discovery.
1. To design a label free, antibody free biosensor array for high throughput
screening of kinase inhibitors. The sensor array should be compatible with
the 96 well microtitre plate such that it is compatible with exiting methods
of sample delivery.
2. To identify a suitable pH sensitive field effect device to act as an ISFET. The
device should be easy to interface with a printed circuit board (PCB). The
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activity of the device will be tested using a single protein kinase inhibitor to
prevent phosphorylation, as a proof of concept.
3. To develop a suitable pH insensitive layer to act as a reference FET. The device
should ideally have no response to the protein phosphorylation reaction or the
presence of the inhibitor.
4. To construct a REFET structure along with the necessary instrumentation
for the biosensor. The ’active’ and the ’inactive’ device should combined to
provide a system for differential measurement such that the reference electrode
can be eliminated.
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Chapter 3
EIS Structures and Organic Thin
Film Transistors for Screening
Protein Kinase Inhibitors
3.1 Design and testing of PCB based EIS
biosensor for Screening Protein Kinase
Inhibitors
3.1.1 Introduction
This section explores the possibility of using an array of EIS capacitive
structures mounted on a PCB as a detection tool for protein phosphorylation. The
suitability of silicon wafers coated with silicon nitride (Si3N4) as EIS biosensors for
the detection of protein phosphorylation was investigated by Nikhil Bhalla et al. in
2015 [112]. EIS structures are field effect devices similar to a metal oxide
semiconductor (MOS) capacitor where the metal layer has been replaced by a
reference electrode immersed in an electrolyte. For this study, the Si3N4 coated
silicon wafers were attached to the copper pads of a PCB to form an electrode
array as an extension of Nikhil’s research.
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Stuart Lindsay in 2012 introduced the concept of associating pH changes
with phosphorylation [114]. The change in pH due to release of H+ ions is responsible
for the change in surface charge of the EIS sensor. By observing the capacitance
versus voltage (C-V) characteristics of the sensor, the change in its surface potential
can be determined.
3.1.2 Materials and Methods
PCB design and processing
A printed circuit board was designed using DesignSpark PCB (version 7.2).
The copper contact pads were distributed such that they fitted under the wells of a
standard 96 well microtitre plate (Figure 3.1). For testing purposes, a small portion
of the PCB (shown in Figure 3.2) containing four contact pads was manufactured on
double sided copper clad FR4 material using an LPKF S63 PCB milling machine.
Figure 3.1: PCB design for the 96 well plate compatible sensor array (160 mm x
180 mm
Multiplexed Biosensors for Drug Discovery Applications 33
Chapter 3
Figure 3.2: Test PCB (52 mm x 25 mm)
P-type silicon wafers (obtained from the University of Applied Sciences
Kaiserslautern), coated with 50 nm of silicon dioxide and 100 nm of silicon nitride
with 100 nm of aluminium deposited as a back contact, were used for this study.
To clean the wafers RCA cleaning was attempted at first. The wafers
were cut into approximately 7mm squares using a diamond scribe. Then they were
immersed in a solution of NH4OH:H2O2:H2O (1:1:5) for 5 minutes at (90
◦C). This
step was performed to remove organic contaminants from the surface. After a
thorough rinse in DI water, the wafers were immersed in HCl:H2O2:H2O (1:1:6) for
5 minutes to remove inorganic contaminants. The wafers were rinsed in DI water
and dried in nitrogen gas [112]. Unfortunately, this process resulted in the removal
of the aluminium back contact on the wafers. Some deposits of aluminium could
be observed on the silicon nitride surface. The use of other rigorous chemical
cleaning techniques like piranha cleaning was avoided as the acids used in these
techniques could similarly damage the wafers. Instead, they were rinsed
thoroughly with acetone and isopropanol and dried with nitrogen gas followed by
UV-Ozone cleaning.
Biofunctionalisation of the Silicon Nitride Surface
All chemicals were of analytical grade and were used as received, unless
otherwise specified. All aqueous solutions were made with double de-ionised water,
18.2 MΩ cm, with a Pyrogard filter (Millipore, USA). Adenosine tri-phosphate
(ATP), (3-glycidyloxypropyl)trimethoxysilane (GOPTS) and Dulbecco’s
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Phosphate Buffered Saline were purchased from Sigma-Aldrich. The peptide under
test was synthesised in the Department of Pharmacy and Pharmacology,
University of Bath. Protein Kinase C-alpha (PKC-α) human recombinant kinase
produced in Sf9, was procured from SignalChem, UK. PKC lipid activator cocktail
was obtained from Millipore. Kinase inhibitor used in this study, GF 109203X
(90%), was purchased from Sigma Aldrich.
In the study conducted by Nikhil Bhalla, Myelin Basic Protein (MBP)
was used along with two peptides for phosphorylation studies. Peptides are
molecules smaller than proteins which have 50 or fewer amino acids [115]. The
peptides, both containing a single phosphorylation site, were synthesised in the
University of Bath, Department of Pharmacy and Pharmacology. Compared to
Myelin Basic Protein, choosing a peptide is a more cost effective alternative and is
sufficient for proof of concept experiments. In this project one of the two peptides
was used, CRRRKGSFRRKK-OH. It was assessed to be 95% pure by High
Performance Liquid Chromatography (HPLC). The composition was confirmed
using mass spectroscopy. Figure 3.3 shows the structure, sequence, formula and
molecular weight of the peptide.
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Figure 3.3: Structure, sequence, formula and molecular weight of the peptide used
in the study
The silicon nitride coated wafers were attached to copper contacts pads of
the PCB using silver conductive paste (RS PRO Silver Conductive Paint procured
from RS Components Ltd). This conductive paste has a low volume resistivity of
0.001Ωcm when fully hardened. After applying the paste on to the copper pads, the
wafers were attached and the boards were baked at 130◦C for 5 minutes to harden
and improve electrical characteristics as suggested in the product datasheet. This
method proved to be the most successful and reproducible for mounting the wafers
on the PCB. Soldering the wafers directly on to the PCB pads was attempted but
preventing the solder from flowing to the Si3N4 thin film proved to be challenging.
The use of reflow soldering using electrically conductive silver epoxy showed similar
challenges where the top and bottom of the wafer often became electrically shorted.
The sensors were clamped down to the PCB using Teflon tape (3M UHMW tape
procured from RS Components) with a 3 mm diameter circular hole punched to
expose the silicon nitride surface. The tape had the additional benefit of preventing
the edges of the wafer from being exposed and liquids seeping under them. Plastic
wells where attached using silicone sealant leaving a circular interrogation area of
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approximately 7.07 mm2 (shown in Figure 3.4).
To silanise the wafers, both liquid and vapour phases were attempted.
During UV-Ozone cleaning, the silicon nitride surface is oxidised to generate
functional silanol (Si-OH). GOPTS binds covalently to the silanol and leaves a free
epoxy end chain on the surface. The amine group of the peptide can bind to the
epoxy group of the silane. This process is useful in reducing non-specific peptide
absorption on the surface [116]. In the liquid phase, the clean wafers were
incubated in 98% GOPTS for 45 minutes after which they were rinsed in
de-ionized water (DI) to remove the excess silane. In the vapour phase, GOPTS
was heated to its boiling point (120◦C) and the clean wafers were exposed to the
silane vapours for five seconds. They were rinsed with DI water and dried. The
silianised surface contains epoxide groups capable of covalently bonding to the
amine groups of the peptide [117]. The binding usually happens preferentially
through the primary amine [118]. The immobilisation and phosphorylation
protocol was optimised by Nikhil Bhalla [112]. We have attempted to follow the
protocols closely by maintaining the same concentration of reagents and
incubation times. 2 µl of 156 µM peptide solution was dispensed onto the wafers
through plastic wells and left to bind for 40 minutes. Figure 3.5 shows the steps
for immobilising the peptide on the silicon nitride surface. Unreacted sites of
GOPTS were blocked by washing the wafers with 20% ethanol. The epoxide
groups convert to ether on reacting with ethanol [119] . The modified wafers were
allowed to incubate in PBS 7.2 for 30 minutes to stabilise the surface before
conducting further measurements.
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Figure 3.4: PCB used for testing
Figure 3.5: Peptide immobilisation steps
Phosphorylation Studies
The phosphorylation reaction was carried out in phosphate buffered
saline (PBS) at pH 7.2. The reaction volumes were fixed to 50 µl for all replicates
and controls. 1 µM ATP, 2 units of PKC-alpha kinase and 2.5 µl PKC lipid
activator (containing containing 0.5 mg/ml phosphatidylserine and 0.05 mg/ml
diacyglycerol in 20 mM MOPS (pH 7.2), 25 mM β-glycerol phosphate, 1 mM
sodium orthovanadate, 1 mM dithiothretiol and 1 mM calcium chloride) were
added to phosphorylate the immobilised peptide on the surface of the sensor. The
reaction was allowed to take place for 13 minutes before taking the capacitance vs
voltage (C-V) measurements. 13 minutes was the time taken for the
phosphorylation reaction to stabilise as reported by Nikhil in his study [112].
The control reaction was carried out in the presence of ATP and PKC
activator in the absence of the enzyme to prevent the protein phosphorylation
reaction from taking place.
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Device Setup
A silver wire coated in silver/silver chloride ink (ALS Co. Ltd) was used as
a reference electrode. A two electrode setup, with the copper contact pad acting as
the working electrode, was used to measure the capacitance-voltage characteristics
of the sensor. Figure 3.6 shows a schematic of the sensor setup.
Figure 3.6: Schematic of the sensor setup
Capacitance vs voltage (C-V) measurements were conducted using a
CompactStat digital potentiostat (Ivium Technologies, The Netherlands). The dc
voltage between the reference electrode and the copper pad was varied between -2
V and 2 V with a superimposed ac signal of 10 mV at 1 kHz. Initial tests to
investigate pH variations on the silicon nitride surface showed that 1 kHz produced
the most stable and reproducible C-V curves. Measurements at lower frequencies
were not reproducible. The experiments were conducted from within a Faraday
cage to keep noise levels to a minimum. All measurement were performed on three
different test boards containing 4 pads each and the average of the 12 readings
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were considered. The voltage shifts were observed as the shift in threshold voltage.
The errors was determined by the standard deviation of the data. The
measurement setup is shown in Figure 3.7.
Figure 3.7: The experimental setup
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3.1.3 Results and Discussion
pH Sensitivity
Figure 3.8: C-V curves for pH sensing
Figure 3.8 shows the capacitance vs voltage curves for different pH values
on the silicon nitride surface as measured by the Ivium Potentiostat. The wafers
were not silanised for this study. 10 mM PBS with pH 4, 7 and 9 was used for
the measurement. The buffers were prepared by mixing monobasic and dibasic
phosphate solutions at specific ratios. The studies were conducted at 1000Hz in
accordance with the studies conducted by Nikhil Bhalla [112] where the results
at 1000Hz was found to be the most reproducible. A pH sensitivity of 49.2±4.1
mV/pH was achieved. Figure 3.8 shows a small voltage range between -0.5V to
0.5V. As the voltage changes from negative to positive, the EIS structures move
from the accumulation to the depletion region. The change in surface charge due to
change in pH of the electrolyte causes this change to happen at different voltages
for different pH values. The pH sensitivity is measured around the reported voltage
range as this is close to the ’threshold’ voltage at which inversion takes place.
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Stability
After allowing the wafers with peptide immobilised to stabilise for 30
minutes in PBS 7.2, the C-V curves were measured repeatedly for twenty minutes
(Figure 3.9). Any stability measurements carried out prior to the thirty minutes of
stabilisation showed a lack of reproducibility. The wafers silanised with GOPTS in
the liquid phase and vapour phase did not show any differences in the stability
measurements. A maximum of 3 mV shift is observed in the twenty minute
interval. This shows that the surface is stable for carrying out the phosphorylation
studies which require a 13 minute incubation time.
Figure 3.9: Capacitance vs voltage curves depicting the stability of peptide on silicon
nitride surface
Phosphorylation
The surface silanised with GOPTS in the liquid phase produced a noisy
and unstable C-V curve as shown in Figure 3.10. The reason for this is the possible
interaction between the adhesive of the teflon tape and GOPTS which led to the
contamination of the sensor surface. On visual inspection of the sensors, a thin
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translucent film was observed on the surface. The method of silanisation was then
changed to the vapour phase which yielded a smooth C-V curve as shown in Figure
3.11.
Figure 3.10: Left: C-V curve for a blank chip in PBS, Right: C-V curve after
silanization in liquid GOPTS
Figure 3.11: Left: C-V curve for a blank chip in PBS, Right: C-V curve after
silanization in GOPTS vapours
In the study conducted by Nikhil Bhalla the immobilisation of the protein
and peptide is confirmed using the TMB assay. The immobilisation of myelin basic
protein (TMB) on the silicon nitride surface was confirmed by adding an anti-MBP
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antibody followed by a secondary antibody linked with horseradish peroxide (HRP).
TMB, T-4444(3,3,5,5-Tetramethylbenzidine), was then dispensed on the surface and
the absorbance was measured by a spectrophotometer. The expected peak at 450nm
was 10 times higher for the surface with protein immobilised compared to the blank
surface. The results of the phosphoylation studies are shown in Figure 3.12 and
3.13. The sensors modified with peptide were first measured in PBS 7.2. This was
followed by the control reaction in the absence of enzyme. This only produced a
small shift of 3 mV. The phosphorylation reaction produced a much larger shift of
48 mV which was stable after 13 minutes.
Similarly, the inhibition reaction in the presence of kinase inhibitor was
carried out after measurement in PBS and the control reaction. The inhibition
reaction produced a shift of 3 mV similar to the control reaction. The inhibition
and phosphorylation reactions were not performed on the same sensor surface due
to ensure that there are no contamination issues.
When a negative voltage is applied through the solution, the positively
charged holes in the bulk silicon are attracted to the semiconductor-insulator surface.
The maximum capacitance Cmax is the measure of capacitance of the insulator
layer as the behaviour of this device similar to a parallel plate capacitor. When
a small positive voltage is applied, the holes are repelled from the semiconductor-
insulator interface resulting in the depletion of majority charge carriers. Due to
phosphorylation of the peptide, protons are released which are adsorbed on to the
sensor surface resulting in the inversion occurring at a lower voltage.
The capacitance in the accumulation mode is the capacitance of the
dielectric, the silicon dioxide and the silicon nitride in series Cmax.
Cmax = εi/ti
where εi is the permittivity of the insulator and and ti is the thickness of
the insulator layer.
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εi = ε0εr
where ε0 is the permittivity of free space 8.854X10
−14F/cm−1, εr is the
relative permittivity of the insulator (3.9 for silicon dioxide and 7 for silicon nitride).
Taking the thickness of the oxide and nitride layer in consideration, the calculated
capacitance come out be 2.31 nF which is very close to our observed value of 2.25
nF in Figure 3.11. The variability in the maximum capacitance value between
experiments was due to the inability to control the interrogation area on using
silicon sealant as an adhesive.
Figure 3.12: C-V curves for control and inhibitor reactions
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Figure 3.13: C-V curves for control and phosphorylation reactions
Figure 3.14: Voltage shifts from the baseline for control, inhibitor and
phosphorylation reactions
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3.1.4 Conclusion
This study was the first step towards developing a printed circuit board
based biosensor for the screening of kinase inhibitors. Using silicon nitride wafers
attached to a PCB with conductive paste, protein phosphorylation was detected.
However, this approach has some limitations. The process of attaching
silicon wafers to the PCB can be quite laborious when the number of sensors on the
board are increased from 4 to 96. The presence of silver conductive paste made the
process of washing the chips quite challenging as the exposure to liquids results in the
paste dissolving and loss of electrical contact between the PCB and the wafers. The
adhesion provided by the silver paste is only temporary which limits the portability
of the device. On drying completely, the wafers were removed from the surface of
the PCB. The use of silicone sealant to secure the wells makes it challenging to
maintain the same interrogation area in every experiment. While the results were
promising, with a 45mV difference in the phosphorylation and control rections, the
preparation of the sensor was time consuming and unreliable.
In conclusion, this approach works in principle but may not be be very
practical for scaling up to an array of sensors. Therefore, in the following sections,
other techniques were explored to come closer to our aim of developing a portable
sensor array for screening protein kinase inhibitors.
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3.2 Organic Thin Film Transistors as for
Screening Protein Kinase Inhibitors
3.2.1 Introduction
This section evaluates the suitability of gold extended gate organic field
effect transitors (OTFTs) for the detection of protein phosphorylation. OTFTs are
excellent candidates for producing low cost, disposable arrays of sensors. Organic
materials can be coated or printed on a variety of substrates after dissolving them
in solvents. The π-conjugated backbone and side chains present in polymer
semiconductors is responsible for their excellent solubility [120]. Low temperature
and high throughput processes of fabrication like thermal evaporation, screen
printing, inkjet printing and spin coating has made OTFTs a very popular
component in sensors fabricated on flexible plastic, glass, metal foils and paper [93]
[121]. The use of these devices opens up the possibility of an array of extended
gate OTFTs for our final design. The presence of miniaturized TFTs on the same
substrate can eliminate the need to interface the sensor array with an external
MOSFET and aid in further reduction in size of the system.
The sensing principle of OTFTs is based on the interaction between the
analyte and the sensing layer which changes the charge distribution at the
interface between the semiconductor and the sensing layer. The change in the
surface potential affects the flow of current in the device. A comparison between
the electrical characteristics before and after exposure to the analyte can be used
to determine the device response [122].
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3.2.2 Materials and Methods
The extended gate OTFTs were produced and supplied by NeuDrive
Limited. Figure 3.15 shows the layout of the sensor. The chip contains two device
structures, one with width by length ratio (W/L) 9800/10 (extended gate
structures) and the other with W/L 980/10 (test structures). Other than the W/L
ratios, the two structures were alike. More intricate details of the devices was not
provided by the company to maintain confidentiality.
The fabrication was done on an 8-inch square glass wafer coated in an
acrylate polymer. The gold source-drain electrodes (50 nm) were deposited by
sputtering followed by patterning using photolythography and wet etching. The
organic semiconductor material, 3-flouro-4-methoxythiophenol in solution, was
deposited on the substrate followed by a number of post-processing steps. The
gold gate electrode (50 nm) was thermally evaporated and patterned using
photolithography and wet etching. Three layers of passivation were added with
SU-8 and PVA [123]. The details steps for fabrication was not disclosed by the
company.
Figure 3.15: EG-OTFT layout (S/D symbolises the interchangeable source and drain
connection) [Image source: NeuDrive extended gate transistor sensors datasheet]
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1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC),
N-hydroxysuccinimide (NHS), 11-mercaptoundecanoic acid (MUA),
6-mercapto-1-hexanol (MCH) and ethanolamine were procured from Sigma
Aldrich. The remaining materials used in this study are similar to section 3.1.2.
The enzyme PKC-alpha was purchased from ProSpec-Tany TechnoGene Ltd.
Biofuctionalisation of Gold Surface
The gold extended gate areas were cleaned by rinsing in ethanol followed by
UV-Ozone cleaning (covered in aluminium foil with only the EGs exposed). Initial
attempts to clean by sonication in ethanol resulted in the removal of the gold from
the glass wafers. A thick PDMS block with holes punched through to expose the EG
areas was used to contain the liquids used in the study. This method proved difficult
to produce a leak proof container because of the weak bonding between PDMS and
the passivated glass substrate. It was not possible to activate the glass surface
using techniques like oxygen plasma cleaning as the devices would be damaged in
the process. Instead, teflon tape with hole punched in it to expose the extended
gates was used as wells. A self assembled monolayer (SAM) made of 1 mM MUA
and 1 mM MCH in ethanol in the ratio of 1:9 was prepared on the gold surfaces
by incubation for 18 hours after which the extended gate areas were rinsed in DI
water. To cover any pin holes on the surface a 1 hour backfilling step with 1 mM
MCH was performed. After rinsing the wafers, an aqueous mixture of 40 mM EDC
and 10 mM NHS was used to activate the SAM. The wafers were rinsed and dried
with nitrogen gas. 2 µl of 156 µM peptide solution was dispensed on to the surface
for 1 hour and then washed with DI water. The unreacted MUA sites were blocked
incubating in 10 mM ethanolamine pH 8.5 [124] [125] for 5 minutes. The extended
gate areas were rinsed thoroughly to remove any traces of ethanolamine from the
surface. The prepared surfaces were incubated in PBS 7.2 for 30 minutes to stabilise
before performing any measurements. Figure 3.16 shows the immobilization steps.
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Figure 3.16: Immobilization of peptide on the gold extended gates
Measurement Setup
Contacts were made on gold contact pads using needle electrodes. The
drain current versus gate voltage measurements were conducted using Agilent
B1500A semiconductor device analyser. A fixed drain to source voltage of -2 V was
maintained throughout the experiment. The gate voltage was varied from -20 V to
20 V. This was applied through an Ag wire coated in AgCl paste as a reference
electrode or the control capacitor present on the chip. The measurements were
performed in a closed Faraday cage to minimise exposure to light because the drain
drifts with time due to photo-generated charges with change in illumination levels.
The phosphorylation reaction was carried out in the same manner as described in
the section 3.1.2. For all replicates, the reaction volume was fixed to 50 µl. All
measurements were performed in three individual wafers with two extended gates
each and the average values were considered. The errors were calculated using the
standard deviation of the data. The shifts in threshold voltage were observed.
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3.2.3 Results and Discussion
Characterisation of the OTFTs
The test structures on the TFTs (W/L=980/10) chips were first used to
understand the characteristics of the sensor. The test structures do not have
extended gates and hence the gate voltage was applied directly to them. The
Figure 3.17 and 3.18 shows the characteristics of the extended gate structures and
test structures respectively.
It is evident from the graphs that the devices have different threshold
voltages even though they are meant to be identical. The two test structures have
a difference of 7 V between their threshold voltages. The difference between the
extended gate structures is less pronounced and a 1.2 V difference in threshold
voltage was observed. It is evident that baseline will vary significantly between
experiments as there are some inherent differences between the structures on the
chip.
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Figure 3.17: Drain current versus gate voltage for the extended gate structures
(drain to source voltage=-2V)
Figure 3.18: Drain current versus gate voltage for the test structures (drain to source
voltage=-2V)
Multiplexed Biosensors for Drug Discovery Applications 53
Chapter 3
Stability
The stability of the extended gate structures was measured after
immobilizing the peptide on the gold surface and incubating in PBS buffer pH 7.2
for 30 minutes. The current vs voltage characteristics (shown in Figure 3.19 and
Figure 3.20) confirmed that the stability of the surface was poor. The shift in gate
voltage over 10 minutes was upto 1 V. The stability measured through the control
capacitor on the chip was less reliable than the reference electrode. The devices
showed a significant drift in drain current when exposed to light (Figure 3.21).
The photogenerated charge carriers resulted in a noisy signal. The signal to noise
ratio changed from 13.9 dB in the absence of light to 129.3 dB in the presence of
light. The lack of stability of the surface and the drift in drain current with time
made it difficult to achieve reliable and reproducible results from the devices.
Stable OTFTs in literature have shown only a 0.2 V long periods of time,
exceeding 9,000 minutes [126].
Figure 3.19: Drain current versus gate voltage for the extended gate structures
measured using a reference electrode depicting the stability of the peptide on the
gold surface (drain to source voltage=-2V) Left: OTFT 1 Right: OTFT 2
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Figure 3.20: Drain current versus gate voltage for the extended gate structures
measured using the control capacitor depicting the stability of the peptide on the
gold surface (drain to source voltage=-2V) Left: OTFT 1 Right: OTFT 2
Figure 3.21: Drain current versus gate voltage in the presence and absence of light
Phosphorylation Reaction
Results of the protein phosphorylation reaction are shown in Figures 3.22
and 3.23. The I-V curve for the extended gates structures were first measured in PBS
7.2 for fixing a baseline. The following measurements were taken after incubation
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in the measuring solution for 13 minutes. The control reaction containing 1 µM
ATP along with 2.5 µl PKC lipid activator showed an average shift of 502 mV from
the baseline. On addition of the kinase inhibitor along with the PKC-α enzyme,
the signal shifted to an average of 726 mV from the baseline. In the absence of the
inhibitor, the protein phosphorylation reaction showed a shift of 2612 mV shift.
These large shifts cannot be attributed to the reaction alone and are
heavily influenced by the instability of the surface and the drift in drain current
over time with change in illumination levels. Considering that the drain current
drift in 10 minutes was already quite high, it is highly likely that the baseline of
the measurements have shifted considerably in 13 minutes incubation. The error
margins for each of the readings are 50 percent or higher which clearly indicate the
lack of reproducible data. Even after 20 minutes of incubation in with the
measuring solution, a stable and reproducible result could not be achieved.
Figure 3.22: Drain current versus gate voltage for the extended gate structures for
the control, inhibition and phosphorylation reactions (drain to source voltage=-2 V)
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Figure 3.23: Voltage shifts from baseline for control, inhibition and phosphorylation
reactions
3.2.4 Conclusion
The study of this batch of extended gate OTFTs show that they are
unsuitable for use as a high throughput detection method for protein
phosphorylation. The primary reason being the inability to achieve a stable
reading when the peptide is immobilized on the gold extended gates. The drift in
drain current with time and illumination levels makes it difficult to fix the baseline
for the measurements. While some large shifts can be seen after protein
phosphorylation as compared with the control and inhibition reactions, they
cannot be attributed to the reaction alone due to the above mentioned reasoned.
Reliability, reproducibility and stability are essential features of a good biosensor
and therefore the OTFTs were not further investigated as a part of this research
project.
It is also to be noted that the devices were prone to damage when using
needle electrode for measurement. The gold contact pads were easily scratched
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resulting in loss of connectivity and the need to repeatedly adjust the point of
contact. The use of a glass wafer as a substrate is more expensive than FR4. Due
to these drawbacks, in the next chapter we have returned to the FR4 substrate.
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Chapter 4
Developing a Sensitive and an
Insensitive Sensor for Screening
Protein Kinase Inhibitors
4.1 MOSFET with Tin Oxide Extended Gate for
Screening Protein Kinase Inhibitors
4.1.1 Introduction
This chapter describes the development of an extended gate field effect
transistor (EGFET) based biosensor for screening protein kinase inhibitors. The
configuration of the EGFET results in the isolation between the chemical/biological
environment and the field effect transistor. The membrane used for biosensing is
connected to the gate terminal of a FET through an conductive layer extending from
the MOSFET chip. There are several advantages of the EGFET structure. This
structure allows the sensing membrane to be processed and modified independent of
the transducer. Low cost disposable biosensors can be fabricated easily by replacing
the extended gate while keeping the measuring circuitry constant. EGFETs have
been reported in literature to have very low sensitivity to changes in illumination
[127] [128] [24]. In a study conducted by Chi et al. extended gates made of tin oxide
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showed only a small shift of 3mV when exposed to 2000lx illumination [129]. .
Moving on from the studies described in section 3.1, the sensing film was
thermally deposited directly on the PCB instead of pasting with conductive silver
paste. Silicon nitride could not be used in this study because it needs temperatures
higher than 300◦C for in-situ deposition by chemical vapour deposition. Typically,
silane (SiH4) and ammonia (NH3) gas react at high temperatures to produce silicon
nitride which is deposited on the substrate. The FR4 substrate have an operating
temperature between -50 to 110◦C and a glass transition temperature1 of 135◦C
[Source: Materials for Printed Circuit Boards http://www.nanotech-elektronik.pl].
The chemical vapour deposition of Si3N4 on PCB is therefore not possible.
The material chosen for the sensing layer is tin oxide. Several metal oxides
were considered for this purpose. The reason for selecting this material is its excellent
pH sensitivity and low cost. pH sensitivity of metal oxides was analysed by Yates
et al. in 1974 using the site binding model . An equilibrium between the AOH sites
on the surface (A is the metal) and H+ ions in the solution is responsible for the
charging of an oxide [131].
AOH
Ka←−→ AO– + Hs+
AOH2
+ Kb←−→ AOH + Hs+
Hs+ are the H+ ions located near the surface of the metal oxide and Ka and
Kb are equilibium constants of the above equations. For the pH sensitive material,
the surface potential is determined by the H+ ions exchanged between the solution
and the binding sites on the surface of the sensor [132].
Silicon dioxide is cost effective and easy to deposit using thermal
evaporation but has been shown in literature to have low pH sensitivity of about
20-40 mV/pH with a non-linear response [133] [134]. Al2O3 shows a good pH
1Glass transition temperature is the temperature at which the polymeric substrate changes from
a rigid glassy material to a soft material [130]
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response of about 53-57 mV/pH [133] [134] and can be deposited by both thermal
and electron beam evaporation. Unfortunately, the evaporator (Auto 306 Vacuum
Coater, BOC Edwards) failed to reach the temperature required for this
deposition. The other option considered was to deposit aluminium and anodise it
to produce aluminium oxide. This was not attempted because the process of
anodisation requires the electrode to be dipped in sulphuric acid which may react
with the copper from the PCB substrate. Furthermore, anodised aluminium has
been shown to produce a nanoporous alumina thin films with low pH sensitivity of
23 mV/pH [112]. Tantalum oxide thin films have shown excellent pH sensitivity
between 55-59 mV/pH with a linear response [134]. This can be deposited easily
using electron beam evaporation. Tin oxide has a similar range of pH sensitivity
and the thin films can be fabricated by thermal evaporation. Both materials are
equally inexpensive. The initial experiments were conducted using tin oxide with
the intention of evaluating tantalum oxide at a later stage.
MOSFETs are one of the most widely used electronic devices. They are cost
effective and easily available. MOSFET based sensors have been used extensively
for gas sensing, biosensing ans chemical sensing to name a few. The main advantage
of these devices is the high input impedance and excellent sensitivity. The change is
surface charge at the gate terminal can results in the change in electrical field and can
easily be measured from a change in drain current [135]. The device consists of three
terminals; namely drain, gate and source. The substrate forms the fourth terminal.
Figure 4.1 shows the structure of a typical n-channel MOSFET. The source and
drain are isolated by the substrate, preventing the flow of charges between the two n+
terminals. When a positive voltage is applied at the gate terminal, minority charge
carriers (electrons) from the p-type substrate are attracted to the semiconductor-
insulator interface. Simultaneously, the holes at the interface are repelled. The
voltage at which this conductive channel begins to appear is called the threshold
voltage [136].
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Figure 4.1: Structure of an n-channel MOSFET
Now, if a potential difference is applied between the source and drain
terminals, a current can flow. When a potential difference between source and
drain exist but the gate voltage is lower than the threshold voltage, no current can
flow because no channel exists. The MOSFET is said to be ’off’. On the other
hand, when the gate voltage exceeds the threshold voltage, a current flow takes
place as the device is ’on’. Ideally, the gate terminal does not draw any current
due to the presence of the insulator [136].








where Cox is the oxide capacity, µ is the electron mobility in the channel, W/L is
the ratio of width and length of the channel, Vt is the threshold voltage.




and the applied drain to source voltage are constant, the drain current IDS is a
function of the gate to source voltage VGS.
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4.1.2 Materials and Methods
Fabrication of Extended Gates
A printed circuit board (PCB) containing four contact pads was made using
the LPKF S63 PCB milling machine on double sided copper clad FR4 material. The
dimensions and distances between the pads were decided keeping in mind the 96 well
microtitre plate. The PCB was cleaned by sonication in acetone and isopranol for
5 minutes each and dried.
10 nm of aluminium was thermally evaporated on to the copper pads
from a tungsten boat to act as an adhesion layer between copper and tin oxide.
SnO2 as sensing layer was then evaporated from an alumina coated tungsten wire
basket. The contacts were masked with kapton tape. The thickness of each layer
was confirmed using a profilometer (DekTak 6M profiler). Through a series of pH
sensitivity experiments, 150 nm of tin oxide was found to be the optimum
thickness for the biosensor. The PCBs were used for sensing without further
cleaning. Figure 4.2 shows the PCB coated in tin oxide.
Figure 4.2: PCB coated in tin oxide and aluminium
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Silanisation of SnO2 thin films
It was necessary to determine whether the film could be silanised because
it is an important step for immobilisation of the peptide under study. Silanisation
of tin oxide has been reported in literature [137]. 3-Aminopropyl)triethoxysilane
(APTES) was used for this part of the study instead of GOPTS. APTES contains
positively charged -NH2 groups. If the silanisation of the surface is successful, a
shift in I-V characteristics will be observed when the thin films are used as extended
gates to a CMOS chip. GOPTS does not contain any detectable charge and hence
it will not be possible to determine whether the surface has been silanisaed by this
method. A 1% (3-Aminopropyl)triethoxysilane (APTES) (purchased from Sigma
Aldrich) solution was prepared in acetone and dispensed on the thin films. The
petridish containing the PCBs was sealed with parafilm and incubated at room
temperature for two hours. The films were rinsed thoroughly in DI water and dried
before curing in a temperature controlled oven for five minutes at 90◦C [138]. An
aqueous solution of 15% glutaraldehyde (Sigma Aldrich) was dispensed on the films
for three hours which were then rinsed thoroughly with DI water and dried.
Immobilisation of peptide
GOPTS was heated to its boiling point (120◦C) and the clean films were
exposed to the silane vapours for five seconds. They were rinsed with DI water
and dried. The silianised surface contained epoxide groups capable of covalently
bonding to the amine groups of the peptide [117]. 2 µl of 156 µM peptide solution
was dispensed onto the films and left to bind for 40 minutes. Unreacted sites of
GOPTS was blocked by washing the wafers with 20% ethanol. The epoxide groups
convert to ether on reacting with ethanol [119]. 50 µl of PBS buffer pH 7.2 was
dispensed on to the modified thin films and the sensing surface was allowed to
stabilise for 30 minutes.
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I-V measurements
The modified PCBs were connected to the gate terminal of an n-type
MOSFET for measurement. The drain current vs gate voltage for the MOSFET
with gate voltage applied directly to the gate terminal is shown in Figure 4.4. This
device was fabricated by Austria Microsystems with the 0.35 µm CMOS process.
The W/L ratios for the NMOS and PMOS are 104/24 and 2104/24 respectively. A
variable gate to source (VGS) voltage of 0-3 V was applied through a reference
electrode (silver wire coated with silver chloride paste) dipped in PBS buffer pH
7.2. Agilent B1500A HR CMU Semiconductor Device Analyser was used to record
drain current vs gate voltage measurements for a fixed drain to source voltage
(VDS) of 50 mV. The typical threshold voltage for for the MOSFET at VDS of 50
mV is 0.4 V. The measurements were performed in a closed Faraday cage in order
to minimise noise. For all replicates, reaction volumes were fixed to 50 µl.
Measurements were performed on three PCBs containing 4 sensors each and the
average values were considered. The errors were calculated from the standard
deviation of the data. Shifts in the threshold voltage were observed. Figure 4.3
shows the schematic of the sensor setup.
Multiplexed Biosensors for Drug Discovery Applications 65
Chapter 4
Figure 4.3: Schematic of the sensor setup
Figure 4.4: Drain current versus gate voltage of MOSFET
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4.1.3 Results and Discussion
pH sensitivity
Different thicknesses of tin oxide from 50-300 nm was deposited on the
PCB and tested for their pH sensitivity. The films were hydrated for 30 minutes
with de-ionized water before the tests. 10 mM PBS with different pH was used for
the measurement. 150 nm of tin oxide showed the highest pH sensitivity of 51.3±1.2
mV/pH while the 50 nm film showed the lowest pH sensitivity of 32.7±2.0 mV/pH.
The pH sensitivities for different thicknesses of tin oxide are shown in Figure 4.5
and Table 4.1. The changes in pH sensitivity between 100nm and 300nm of tin
oxide are not significant but this experiment was conducted solely for the purpose
of selecting a thickness of the sensor layer. Since the best pH sensitivity was shown
by 150nm, this was the thickness chosen for the rest of the experiments. The drain
current versus gate voltage for 150nm of tin oxide for different pH is shown in Figure
4.6. Thermally evaporated tin oxide films of 150nm thickness have been shown to
possess a pH sensitivity of 58 mV/pH in literature [139].
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Figure 4.5: pH sensitivity of different thicknesses of thermally evaporated tin oxide
thin films







Table 4.1: pH sensitivity of thermally evaporated SnO2 thin films ranging from
50-300 nm
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Figure 4.6: pH response of SnO2 150nm thin film
Temperature sensitivity
Temperature sensitivity was measured with PBS 7.2 between 0-50◦C in
5◦C increments. PBS buffer at 0◦C was heated slowly in a temperature controlled
water bath. The temperature of the PBS was monitored closely with a
thermometer immersed in buffer. For every 5◦C increment, the PBS was dispensed
on to the extended gates and the measurements were conducted immediately. The
films were hydrated in PBS pH 7.2 at room temperature for thirty minutes prior to
the measurements. There was a significant difference between the temperature
sensitivity observed between 0-20◦C and between 20-50◦C (Figure 4.8 and Figure
4.7. Between 0-20◦C the temperature sensitivity was found to be 1.0 mv/◦C.
Between 20-50◦C a temperature sensitivity of 0.2 mV/◦C observed. The reasons
for this difference could not be determined. It was expected that the temperature
sensitivity would be roughly uniform for the entire experiment.
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Figure 4.7: Drain current vs gate voltage for different temperatures on SnO2) thin
film. Left: 0-20◦C Right: 20-50◦C
Figure 4.8: Voltage shifts for different temperatures on tin oxide thin film
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Silanisation with APTES
Figure 4.9: Drain current vs gate voltage for silanisation of tin oxide with APTES
followed by treatment with glutaraldehyde (GAD)
APTES is used to test whether the tin oxide surface can be silanised.
Organosilanes form a self assembled monolayer on metal oxide surfaces. The reason
for choosing APTES over GOPTS for this test is the because of the presence of
positively charged amino [140] groups on APTES which can be detected as a shift
in the drain current vs gate voltage characteristics of the MOSFET. On silanisation,
a large shift of 180 mV was observed. Glutaraldehyde was used to neutralise the
positive charge by adding aldehyde groups to the surface [141]. After the addition
of glutaraldehyde the I-V characteristics return to 5 mV of the baseline (Figure
4.9). While this experiment proved the possibility of the tin oxide thin films being
silanised, the shifts were unexpectedly high.
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Stability
Figure 4.10: Stability of the tin oxide thin films with peptide immobilised
The stability of the SnO2 thin films were measured after silanisation in
vapour phase with GOPTS and immobilisation of peptide. Following the
immobilisation, the films were left to stabilise in PBS 7.2 for 30 minutes before the
test. The results are shown in Figure 4.10. The voltage shifts over ten minutes was
a maximum of 2 mV. The surface proved to be stable for performing the
phosphorylation studies.
Phosphorylation Reaction
The results of the phosphorylation reaction are shown in Figure 4.11. The
I-V curves were first determined in PBS buffer pH 7.2 to ascertain the baseline.
Each of the measurements were conducted after 13 minutes of incubation in the
measuring solution. The control reaction was conducted with 1 µM ATP and 2.5 µl
PKC lipid activator. An average shift of 30 mV from the baseline was observed. On
addition of the kinase inhibitor along with PKC-α enzyme, the signal shifted by an
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average of 33 mV from the baseline. The phosphorylation reaction was conducted
in the presence of ATP, activator and enzyme. A large shift of 83 mV was observed.
The signals from the control and inhibition reaction were comparable but
the size of the shift was very large and unaccounted for because without the
phosphorylation reaction taking place, charged species were not produced. The
effective shift for the phosphorylation signal (phosphorylation signal-control signal)
is 53 mV. The size of the shift from the baseline however, is too large to be
attributed to the reaction alone. In the following subsection, attempts to
troubleshoot this problem has been discussed. It is unlikely that the pH insensitive
reference sensor for the final REFET will have the similar large responses for the
control or inhibition reactions and therefore it is necessary to explore methods of
reducing these signals.
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Figure 4.11: Top Left: Drain current vs gate voltage for the control reaction for
tin oxide thin films on a PCB. Top Right: Drain current vs gate voltage for the
phosphorylation reaction for tin oxide thin films on a PCB. Bottom Left: Drain
current vs gate voltage for the inhibition reaction for tin oxide thin films on a PCB
Bottom Right: Voltage shifts for phosphorylation studies for tin oxide thin films on
a PCB
4.1.4 Troubleshooting the Biosensor
Interaction of individual solution components with the thin films
In the first attempt, it was hypothesised that one or more of the solution
components were reacting with the surface of the thin film. To test this theory, the
thin films were incubated individually in PBS buffer pH 7.2 containing the
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enzyme, PKC lipid activator, ATP and inhibitor separately. The concentration of
the individual components in solution was kept the same as that in the
phosphorylation studies. The enzyme, ATP and activator individually did not
show any significant voltage shifts. The inhibitor, however, showed a significant of
12 mV shift (Figure 4.12).
The thin films with immobilised peptide was allowed to incubate in PBS
pH 7.2 for 30 minutes followed by inhibitor for 13 minutes before phosphorylation
studies were conducted. The average shifts did not show a significant change after
employing this method (Figure 4.12). There was a small decrease of 2 mV for the
phosphorylation signal from the previous 83 mV to 81 mV. The inhibition reaction
showed a reduction in signal by 7 mV and the control reaction by 3 mV only. This
approach did not prove to successful to be reduce the large signals.
Figure 4.12: Left: Voltage shifts for phosphorylation studies on tin oxide thin film on
PCB after incubating the surface with inhibitor. Right: Voltage shifts for interaction
of individual solution components with tin oxide thin film on a PCB
Replacing tin oxide with tantalum oxide
In the next attempt, tin oxide was replaced with a different metal oxide,
tantalum pentoxide (Ta2O5). This is also a pH sensitive material that has been
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widely used as a pH sensor and a biosensor [142] [143] [144].
The method of deposition of the thin films was similar to tin oxide. The
PCBs milled from double sided copper clad FR4 material were cleaned by
sonication in acetone and isopropanol for five minutes each. 10 nm of aluminium
was deposited by thermal evaporation as an adhesion layer after which 150 nm of
tantalum pentoxide was evaporated from a copper crucible by electron beam
evaporation. The thin films were used without any further cleaning.
This approach resulted in films which easily dissolved when exposed to
PBS buffer or by washing. To improve the adhesion of the films, a thicker adhesion
layer of 100 nm of aluminium was deposited. This only marginally improved the
adhesion of the films. Chromium and titanium were also used as adhesion layers by
thermal evaporation but did not prove to be successful.
Finally, the PCBs were polished using 5 µm alumina slurry for 8 minutes
to remove the thin surface layer of copper oxide and produce a smoother surface
for deposition. The PCBs were cleaned once again by sonicating in acetone and
isopropanol for 5 minutes each before depositing 10 nm of aluminium and 150 nm of
Ta2O5. This significantly improved the adhesion of the thin films and further studies
on pH sensitivity, stability and phosphorylation were conducted on these PCBs.
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pH sensitivity
Figure 4.13: Drain current vs gate voltage characteristics for pH sensitivity studies
The Ta2O5 films were incubated in PBS 7.2 for 30 minutes before the pH
sensitivity studies. A pH sensitivity of 53.2±2.2 mV/pH was achieved in this study
(Figure 4.13. The thin films become prone to dissolution at pH less than 5 and
higher than 9. pH sensitivities of Ta2O5 thin films has been found to range between
55-59 mV/pH in literature. [134]
Stability
The Ta2O5 thin films were silanised with 98% GOPTS in vapour phase,
similar to the SnO2 thin films. 2 µl of 156 µM peptide was dispensed on the
surface and left to bind for 40 minutes. The stability of Ta2O5 thin films with
immobilised peptide were measured after incubation in PBS 7.2 for thirty minutes.
The results proved that the surface was stable with a maximum shift of 2 mV in
10 minutes (Figure 4.14). It is important to note here that the 20 minute data
could not be collected for the devices used in this experiment because the thin
films were either wholly or partially removed from the surface by this point. In
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order to continue with the same devices towards the phosphorylation experiments,
the stability measurements were conducted for only 10 minutes.
Temperature sensitivity of the films could not be tested because the films
showed a tendency to be removed easily from the surface on washing when exposed
to different temperatures.
Figure 4.14: Stability of Ta2O5 thin films on a PCB with immobilised peptide
Phosphorylation
The results of the phosphorylation reaction are shown in Figure 4.15. The
I-V curves were first determined in PBS buffer pH 7.2 to fix the baseline. Each of
the measurements were conducted after 13 minutes of incubation in the measuring
solution. The control reaction was conducted with 1 µM ATP and 2.5 µl PKC lipid
activator. An average shift of 8 mV from the baseline was observed. On addition
of the kinase inhibitor along with PKC-α enzyme, the signal shifted by an average
of 10 mV from the baseline. The phosphorylation reaction was conducted in the
presence of ATP, activator and enzyme. A shift of 47 mV was and an effective
phosphorylation signal of 39 mV is observed.
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The Ta2O5 thin films show some promising results but were not further
investigated. The of the deposited films continued to be prone to dissolution on
repeated washing which is a necessary step in the studies described. The above
results were reported from films that did not dissolve through the duration of the
experiment. The number of useful devices per fabrication cycle was an average of
50%. The term ’useful’ refers to those devices that retained the thin film on the
PCB substrate through the entirety of the phosphorylation experiment.
Figure 4.15: Top Left: Drain current versus gate voltage for control reaction
for tantalum oxide on a PCB. Top Right: Drain current versus gate voltage for
phosphorylation reaction for tantalum oxide on a PCB. Bottom Left: Drain current
versus gate voltage for inhibition reaction for tantalum oxide on a PCB. Bottom
Right: Voltage shifts for phosphorylation studies for tantalum oxide on a PCB
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Tin oxide on polished PCB
The results of the troubleshooting experiments proved that polishing the
PCBs prior to thermal deposition improved the adhesion of the thin films. There
was roughly a 20% increase in ’useful’ devices when the PCBs were polished before
the deposition of Ta2O5. The same technique was employed to make the tin oxide
coated PCBs. As mentioned above, the copper pads of the PCBs were polished
with 5 µm alumina slurry for 8 minutes. The remaining steps were kept the same
as section 4.1.2. The tests for pH sensitivity, temperature sensitivity, stability and
phosphorylation was performed.
The surfaces of the polished and unpolished PCBs were investigated using
images from a Scanning Electron Microscope (SEM) as shown in figure 4.16. The
SEM (Jeol JSM-6480LV) images revealed that the unpolished PCBs contained a
rough, undulating surface containing crests and troughs often as large as a few
microns. The polished PCBs revealed a smooth surface with no such irregularities.
The images shown in the figure are only upto X6,000 magnification because it was
not possible to focus the images at larger values of magnification. The SEM images
indicate that the deposition of the thin film on the unpolished PCBs were possibly
not uniform and that there a possibility of copper being exposed through them.
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Figure 4.16: SEM Images (Top Left and Bottom Left: Unpolished Copper Surface
of the PCB, Top Right and Bottom Right: Polished Copper Surface of the PCB)
To investigate the surface roughness further, Atomic Force Microscopy
(AFM) was used. The figures 4.17 and 4.18 show the three dimensional
representation of the AFM (Nanoscope IIIA microscope) data for a 1µm2 area.
The mean roughness for the unpolished PCB was 6.62nm. The polished PCB
yielded a significantly lower mean roughness of 2.43nm. The improvement in
surface roughness by 63.2% could be responsible for better adhesion of the films.
The rough surface with a discontinuous and porous film may have allowed for
solutions to penetrate under it, resulting in its removal.
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Figure 4.17: 3D AFM Image of Unpolished Copper Surface of PCB
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Figure 4.18: 3D AFM Image of Polished Copper Surface of PCB
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pH sensitivity and temperature sensitivity
Figure 4.19: pH sensitivity studies for tin oxide thin films on a polished PCB
Figure 4.20: Temperature sensitivity studies for tin oxide thin film on a polished
PCB in the range of 0-50◦C. Left: Drain current vs gate voltage for different
temperatures Right: Voltage shifts for different temperatures
The results of the pH sensitivity studies is shown in Figure 4.19. The
polished PCBs showed a small increase in pH sensitivity from 51.3±1.2 mV/pH to
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53.7±3.3 mV/pH.
The temperature sensitivity studies were significantly improved as shown
in Figure 4.20. The voltage shifts with temperature was uniform in the 0 − 50◦C.
The results from the unpolished PCB where a . A temperature sensitivity of 0.3
mV/◦C was achieved.
Stability
The stability of the tin oxide thin films after peptide immobilisation on the
polished PCB substrate remained reasonably good as shown in Figure 4.21. Similar
to the previous stability studies, the PCB was left to stabilize in PBS 7.2 for 30
minutes before the experiment. There was a maximum of 4 mV shift in 10 minutes.
Figure 4.21: Stability of tin oxide thin films with immobilised peptide on a polished
PCB substrate
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Phosphorylation
Figure 4.22: Results of phosphorylation studies on tin oxide thin film on a polished
PCB. Top Left: Change in I-V characteristics for the control reaction Top Right:
Change in I-V characteristics for the phosphorylation reaction Bottom Left: Change
in I-V characteristics for the inhibition reaction Bottom Right: Comparison of
voltage shifts during the phosphorylation studies for tin oxide thin film on polished
and unpolished PCB
The results of the phosphorylation reaction is shown in Figure 4.22. A
significant improvement in signal was observed with the polished PCBs. The control
signal was reduced to an average of 8 mV from 30 mV in the unpolished PCBs. The
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large signal of 83 mV for the phosphorylation reaction was reduced to an average of
53 mV. The inhibitor showed a average 7 mV shift from 33 mV in the unpolished
PCBs which is close to that of the control signal. The figure also shows the difference
in signal levels for phosphorylation studies for tin oxide thin films on polished and
unpolished PCB.
Thin Film Control(mV) Inhibition(mV) Phosphorylation(mV)
SnO2 on unpolished PCB 30 33 83
SnO2 on polished PCB 8 7 53
Ta2O5 on polished PCB 8 10 47
Table 4.2: Voltage shifts from phosphorylation studies on tin oxide and tantalum
oxide
The difference in signals between the polished an unpolished PCBs could
be for a variety of reasons. Commercial copper clad FR4 sheets show an uneven,
rough surface when checked under an optical microscope. Deposition of materials on
such substrates can cause the resulting thin film to be uneven with a larger effective
sensor area. The effect of surface roughness of the substrate on the response of tin
oxide thin films was studied by Cricenti et al.. An increase in response by 30% was
observed with the thin films deposited on a rough substrate [145].
Another possible reason for the enhanced signal from the unpolished PCBs
is the chance that the tin oxide deposited on the uneven surface was porous. The
penetration of solutions into the pores would have resulted in false signals being
added to the overall signal [146]. The reason also could be a combination of the
above two. Table 4.2 shows the different values from phosphorylation studies for
SnO2 and Ta2O5.
From the SEM and AFM images, it can also be hypothesised that the
deposited tin oxide thin film on the unpolished PCB might have had copper exposed
through them which eventually entered the electrolyte. Copper has been known to
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behave as a catalyst in several biological reactions [147] and could be hypothesised
that the large shifts were due to some kind of catalytic activity. However, the role
of copper as a catalyst in the phosphorylation reaction has not been investigated
further in this study and therefore remain inconclusive.
4.1.5 Conclusion
This study forms the first part of developing a REFET based biosensor.
The pH sensitive material tin oxide was used to form a thin film on a PCB substrate
which was coupled to the gate of a MOSFET as an extended gate. Even though the
film showed good pH sensitivity and stability, the signals from the phosphorylation
studies was very large. The temperature sensitivity was also variable.
To troubleshoot this problem, tantalum pentoxide was used to replace tin
oxide as the sensing layer on the PCB. Poor adhesion of tantalum oxide was
improved by polishing the PCBs with alumina slurry before deposition of the thin
film. This improved adhesion significantly and the phosphorylation studies showed
some promising results. However, some of the films were still prone to dissolution
on repeated washing.
The above process was applied to the tin oxide thin films and proved to be
very successful in reducing large false signals. The phosphorylation studies showed
smaller signals for control, inhibition and phosphorylation reactions. This technique
was employed in making the sensor film for the REFET and will be explored in later
section.
The limitation of this technique is that the PCBs were polished by hand
and can be difficult to produce a uniform surface when a larger sized PCB is used
for the 96 well plate. Also the films are single use only and cannot be clean and
reused for measurement unlike the silicon nitride coated silicon wafers.
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4.2 Development of the Reference Field Effect
Transistor
4.2.1 Introduction
This section describes the development of the biosensor that can act as
a reference for the final REFET device. Ideally, the sensor should be completely
insensitive to pH and phosphorylation. The passive sensor should closely resemble
the active sensor surface with the exception of having a peptide immobilised on it
which does not contain any phosphorylation sites. The design and synthesis of this
peptide was not attempted due to time constraints. Instead, several attempts have
been made to cover the gate of an ISFET with a ion insensitive membrane of varying
thickness and compositions. Thick layers of materials such as Teflon and PVC (few
microns or higher) have failed to show a low pH response [107] [148]. On the other
hand, thin polymer layers (tens of nanometers) show a linear response to pH with
nearly no change in pH sensitivity. The reason for this is the inability to create
pin-hole free surfaces of such low thickness [149].
Chemical modifications of the gate surface has proved more successful in
producing pH insensitive layers. In one approach, grafting a dense monolayer of long
alkyl-chain silanes was attempted yielding low pH sensitivity of 10 mV/pH [150].
In another attempt the gate was covered with a sodium complex of calixpherand
which showed almost no pH sensitivity [148].
In this study, initially the blocking of active GOPTS sites was attempted.
This is expected to prevent components of the solution from binding to the surface.
Two polymers, namely PDMS and SU-8 were tested for their suitability as the pH
insensitive layer. The most successful attempt was using SU-8. SU-8 is an epoxy
based negative photoresist which is often used as a passivation layer for microdevices
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[151]. SU-8 has been used by to reduce pH sensitivity of surfaces. In a study by
Calleja et al., microcantilevers of SU-8 photoresist were fabricated to eliminate pH
and temperature sensitivity as compared to gold coated silicon nitride cantilevers
[152].
4.2.2 Materials and Methods
Preparing the PCBs
A printed circuit board (PCB) containing four contact pads was made using
the LPKF S63 PCB milling machine on double sided copper clad FR4 material. The
dimensions and distances between the pads were decided keeping in mind the 96 well
microtitre plate (same as Figure 3.23 in the previous section). The PCB was cleaned
by sonication in acetone and isopranol for 5 minutes each and dried. The copper
pads of the board were polished using 5 µm alumina slurry for 8 minutes. The PCBs
were cleaned again by sonication in acetone and isopropanol for 5 minutes each and
dried.
Blocking GOPTS on SnO2 surface
10 nm of aluminium as an adhesion layer was thermally evaporated on to
the copper pads from a tungsten boat. 150 nm of tin oxide was deposited by
thermally evaporation from an alumina coated tungsten wire basket. The contacts
were masked with kapton tape. The thin films were used without any further
cleaning.
To silanise the tin oxide, GOPTS was heated to its boiling point (120◦C)
and the thin films were exposed to the silane vapours for five seconds. They were
rinsed with DI water and dried. The silianised surface contains epoxide groups
capable of covalently bonding to the amine groups of the peptide [117]. The
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epoxide groups convert to ether on reacting with ethanol, preventing the binding
of the peptide [119]. The active GOPTS sites were blocked using 20% ethanol.
Different incubation times of 5, 10 and 15 minutes were considered. Also, 1% and
2% ethanolamine pH 8.5 was used to block the surface. Different incubation times
of 5, 10 and 15 minutes were considered. 50 µl of PBS buffer pH 7.2 was dispensed
on to the modified thin films and the sensing surface was allowed to stabilise for 30
minutes before conducting any experiments.
Passivation with SU-8
PDMS and SU-8 photoresist of different thicknesses were spin coated onto
the cleaned and dried PCBs to act as a pH insensitive layer. The PDMS was cured
at 90◦C for 20 minutes. The SU-8 layers baked for 2 minutes at 90◦C, exposed to
UV radiation and then baked for 2 minutes at the same temperature post exposure.
50 µl of PBS buffer pH 7.2 was dispensed on to films and the sensing surface was
allowed to stabilise for 30 minutes.
Current-voltage measurements
The modified PCBs were connected to the gate terminal of an n-type
MOSFET for measurement. This MOSFET the same as section 4.1.2. A variable
gate to source voltage of 0-3 V was applied through a reference electrode (silver
wire coated with silver chloride paste) dipped in PBS buffer pH 7.2. A fixed drain
to source voltage of 50 mV was maintained. Agilent B1500A HR CMU
Semiconductor Device Analyser was used to record current vs voltage
measurements. The experiments were performed in a closed Faraday cage in order
to minimise the influence of noise. All measurements were performed on three
individual PCBs containing 4 pads each and the average values were considered.
Errors were measured from the standard deviation of the data. Voltage shifts were
Multiplexed Biosensors for Drug Discovery Applications 91
Chapter 4
observed from the shift in threshold voltage. Figure 4.23 shows the schematic of
the measurement setup where the PCB coated with the SU-8 layer layer forms the
extended gate to a MOSFET. The gate voltage is applied to the reference electrode
dipped in the electrolyte (PBS buffer). The connection is similar to the ’active’
devices containing the tin oxide thin films which were described in section 4.1.
Figure 4.23: Schematic of the measurement setup
4.2.3 Results and Discussion
Blocking silanised SnO2 surface
The silanised SnO2 surfaces with the GOPTS sites blocked were used for
the phosphorylation reaction. The solution for the control reaction containing ATP
and PKC lipid activator was dispensed on the surfaces and allowed to incubate for
13 minutes. The voltage shifts for 1% and 2% ethanolamine as well as 20% ethanol
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remained around 10-12 mV irrespective of the blocking time. The solution for the
phosphorylation reaction containing ATP, PKC lipid activator and PKC-α kinase
was dispensed on to the films and after 13 minutes a shift of 27-30 mV was observed
irrespective of the blocking time. Figure 4.24 and 4.25 show the voltage shifts for the
control and phosphorylation reaction. The error bars represent the the variability
in the data over three different PCBs where the measurements were conducted on
each of the four pads.
This process did not prove successful in providing an insensitive surface.
This was probably because it was not possible to block all the available GOPTS sites
and the chemicals in the solutions were attaching to the GOPTS sites or directly on
the surface. The result was the surface being modified and the I-V characteristics
showing a shift. The inhibition reaction was not conducted in this case because the
control and phosphorylation reaction showed significant shifts and the inhibition
reaction would be wasteful.
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Figure 4.24: Top: Shifts in gate voltage for the control reaction for 1% and 2%
ethanolamine (ETA) Bottom: Shifts in gate voltage for the phosphorylation reaction
for 1% and 2% ethanolamine (ETA)
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Figure 4.25: Top: Shifts in gate voltage for the control reaction for 20% ethanol
Bottom: Shifts in gate voltage for the phosphorylation reaction for 20% ethanol
PDMS and SU-8
In the next attempt, PDMS polymer was spin coated on to the copper
pads of the PCB and cured and cured at 90◦C for 10 minutes. The thickness of the
layer was roughly 100 µm. The extended gate measurements in PBS pH 7.2 showed
a noisy signal with low signal strength of a few nanoamps. PDMS was not tested
further because it was difficult to tailor its thickness for further experimentation.
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SU-8 50 µm was then spin coated on to the tin oxide thin films. I-V
measurements showed a signal strength of only a hundred picoamps in PBS pH 7.2
but continued to be very noisy and distorted. This clearly shows that the insulator
layer is too thick and is preventing the effect of the electic field from reaching the
gate of the MOSFET. The signal strength was too low to be considered as a reference
for the final REFET structure. Ideally, the reference FET or the insensitive’ FET
should produce a signal similar to the ’sensitive’ FET when the peptides are not
phosphorylated. In the next attempt, SU-8 50 µm was spin coated directly on to the
copper pads. The rationale behind this was to reduce the thickness of the insulator
at the gate. This would also eliminate any effects at the tin oxide-SU-8 junction.
In some previous experiments where the tin oxide surface was heated, the thin film
showed visible signs for fragmentation. It is possible that the heating required for
curing SU-8 was causing the tin oxide layer to be damaged. The resulting signal
strength improved to the range of microamps . Figure 4.26 shows the results of
these attempts.
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Figure 4.26: Top Left: Drain current vs gate voltage for SU-8 50 µm on SnO2 Top
Left: Drain current vs gate voltage for 100 µm of PDMS Bottom: Drain current vs
gate voltage for SU-8 50 µm on copper
To increase signal strength and reduce the noise, the thickness of the SU-8
film was reduced. The results of the extended gate I-V measurements is shown in
Figure 4.27. For the SU-8 thin film of 10 µm thickness, the on current increased to
microamps. For further noise reduction 2 µm and 115 nm SU-8 was used. The on
current increased to double and the noise level reduced significantly when the SU-8
thickness was changed from 2 µm and 115 nm. The best signal was achieved from the
115 nm SU-8 layer and was used for further experiments on stability, temperature
sensitivity and phosphorylation.
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Figure 4.27: Drain current versus gate voltage different thicknesses of SU-8 thin film
on a PCB substrate
Stability
The stability of the 115 nm SU-8 film was measured after incubation in
PBS pH 7.2 for 30 minutes. The results are shown in Figure 4.28. The shift over
10 minutes was less than 2 mV and can be considered to be stable for further
experiments.
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Figure 4.28: Stability of SU-8 115 nm thin film on a PCB in PBS buffer pH 7.2
Temperature sensitivity
Temperature sensitivity was measured after incubating the SU-8 films in
PBS pH 7.2 at room temperature for 30 minutes. The temperature of the PBS
buffer was varied between 0 and 50◦C with 5◦C increments. For this experiment the
PBS buffer was fist cooled to 0◦C and then heated slowly to 50◦C in a temperature
controlled water bath. The temperature of the PBS was monitored closely during
the experiment by using a thermometer immersed in the in the beaker containing the
buffer. 50µl of PBS at dispensed on the sensor surface for every 5◦C increment and
the I-V characteristics were measured immediately. This was done to prevent the
temperature of the buffer from reaching room temperature during the measurements.
The results are shown in Figure 4.29. A temperature sensitivity of 0.9 mV/◦C was
observed. The error bars represent the variability in data between 3 different PCBs
where all four of the pads were used for measurement.
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Figure 4.29: Temperature sensitivity studies on SU-8 115 nm on a PCB in the range
0-50◦ Left: Drain current vs gate voltage for different temperatures on SU-8 surface
Right: Voltage shifts for different temperatures
SU-8 pH sensitivity
The SU-8 thin films were incubated in PBS pH 7.2 for 30 minutes before
the pH sensitivity studies were conducted. The pH sensitivity archived in this study
was 4.3±1.3 mV/pH.
Figure 4.30: Drain current vs gate voltage for pH sensitivity studies
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Phosphorylation
The results of the phosphorylation reaction are shown in Figure 4.31. The
error bars represent the variability in data between three different PCBs where all
four of the pads were used for measurement. The baseline was determined by first
conducting measurements in PBS buffer pH 7.2. Each measurement was conducted
after 13 minutes of incubation in the measuring solutions. The control reaction was
conducted with 1 µM ATP and 2.5 µl PKC lipid activator. An average shift of 3
mV is observed after 13 minutes. On addition of kinase inhibitor along with PKC-α
enzyme, a large average shift of 27 mV is observed. The phosphorylation reaction
in the presence of ATP, kinase and activator showed a small shift of 4 mV.
The unexpected large shift for the inhibition reaction led to the
investigation of how each of the solution components interact with the SU-8
surface. The SU-8 thin films were incubated with individual solution components
in the same concentration as in the reactions. ATP, activator and enzyme showed
a small voltage shift between 1-2 mV. The activator showed a large shift of 13 mV.
These measurements were conducted over three PCBs were each of the four pads
was used for measurement. Figure 4.31 shows the results of the experiment.
To reduce the surface interactions of the inhibitor, the SU-8 thin films were
incubated in StartingBlock Buffer (PBS) Tween 20 (procured from ThermoFisher)
for 30 minutes before the experiment. StartingBlock buffer contains a single purified
protein and has been shown to successfully block free spaces on the surface to prevent
interactions like non-specific binding [153]. This technique came with the risk that
the protein present in the StartingBlock may phosphorylate. However, no significant
change was observed. The voltage shift for the inhibition reaction reduced by only 3
mV while the control and phosphorylation reaction reduced by only 1 mV each. The
potential for the proteins in the StartingBlock to phosphorylate was not investigated
since this method was not taken forward to develop the reference FET.
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Figure 4.31: Left: Voltage shifts phosphorylation studies on SU-8 thin films on a
PCB Right: Voltage shifts due to interaction of individual solution components with
the SU-8 surface
In the next attempt, the SU-8 thin films were incubated with the
inhibitor in PBS buffer pH 7.2 for 30 minutes before the phosphorylation studies
were conducted. This was done to saturte the surface with inhibitor and eliminate
the effect that was causing the significant shifts. This method proved to be
successful in reducing the large inhibition signal to 2 mV. The control signal was
only reduced by 1 mV while the phosphorylation signal remained constant. Figure
4.32 and Table 4.3 shows the comparison between voltage shifts during the
phosphorylation studies for the plain SU-8 surface, SU-8 surface treated with
StartingBlock buffer and SU-8 treated with inhibitor. Incubating with the
inhibitor may not be ideal when a number of inhibitors are being considered but
this process was followed to move towards the construction of the REFET in the
next chapter.
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Figure 4.32: Voltage shifts due to phosphorylation studies on SU-8 thin films, SU-8
surface treated with StartingBlock Buffer and SU-8 surface treated with inhibitor
Thin Film Control(mV) Inhibition(mV) Phosphorylation(mV)
SU-8 3 27 4
SU-8+StartingBlock 2 24 3
SU-8+Inhibitor 1 2 3
Table 4.3: Voltage shifts from phosphorylation studies su-8
4.2.4 Conclusion
The development of the pH insensitive surface that does not respond to the
phosphorylation reaction forms the second part of the final REFET design. SU-8 as
a pH insensitive material was studied. SU-8 115 nm showed the best and most noise
free signal and was used for further studies. The pH sensitivity was only 4.3±1.3
mV/pH as compared to 53.7±1.2 mV/pH for the tin oxide thin film in section 4.1.
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The SU-8 thin film showed good stability and temperature sensitivity was
not insensitive to all the reactions in the phosphorylation studies. The control
and inhibition reactions showed small changes in voltage but the inhibition reaction
showed a large voltage shift. This was finally minimised by treating the surface with
inhibitor before the phosphorylation studies. While this process adds an extra step
to the making of the biosensor, a more effective process to suppress the inhibition
signal was not discovered during this study. The aim would be to construct two
surfaces that closely resemble one another except one is active and the other is
passive. One approach would be to deposit tin oxide on both surfaces but modify
one with the peptide containing one phosphorylation site and the other with a
peptide containing no phosphorylation sites. This technique will be used to make
the reference FET for the REFET based biosensor and will be detailed in the next
chapter.




for Screening Protein Kinase
Inhibitors
5.1 Introduction
In this chapter the attempts to put the REFET structure together and use
it for the purpose of biosensing is described. A commercially available MOSFET IC
ALD1106 (Advanced Linear Devices, Inc) containing matched pair FETs is used for
extended gate measurements using the tin oxide and SU-8 thin films on a PCB as
extended gates. The FETs on this IC have low gate leakage current, typically 0.1
pA and a maximum of 10 pA. Leakage currents can result in addition of false signals
and therefore a MOSFET with a low gate leakage desirable [154]. The differential
measurement between the ’sensitive’ and the ’insensitive’ surfaces eliminates the
need for a reference electrode.
Next, A PCB was designed such that each well of the 96 well microtitre
plate contained 3 copper pads. Two of them act as extended gates to the matched
pair transistors for differential measurements and the third acts a ground
connection. The four sets of copper pads were multiplexed using an analog
multiplexer IC CD74HC4052 (Texas Instruments) after amplification through an
Multiplexed Biosensors for Drug Discovery Applications 105
Chapter 5
instrumentation amplifier AD620 (Analog Devices). The data was digitised, logged
and processed by an Arduino Uno connected to a PC. For the array of 96 REFET
structures, a decoder IC will be required for addressing the multiplexers but for
the test board this was not used. This setup will help us move towards a portable
system of screening protein kinase inhibitors. Similar to the previous chapters, a
single protein kinase inhibitor was tested on this device as a proof of concept.
Different inhibitors have not been considered on this occasion and forms a part of
the future work.
5.2 Materials and Methods
Fabrication of REFET
A printed circuit board was designed using DesignSpark PCB (version 7.2).
The copper pads were distributed such that they fit under a 96 well microtitre plate.
Three pads were placed under each well to form a REFET structure. For testing
purposes a small portion of the PCB containing 4 sets of pads was manufactured on
double sided copper clad FR4 material using an LPKF S63 milling machine. Figure
5.1 shows the PCB design for the test board and Figure 5.2 shows the PCB once
manufactured.
The boards were cleaned by sonicating in acetone and isopropanol for 5
minutes each. The copper pads were polished for 8 minutes using 5 µm alumina
slurry to remove the thin layer of copper oxide and make the surface smoother. The
alumina residue was removed by sonicating in acetone and isopropanol again for 5
minutes each.
SU-8 photoresist 115 nm was spin coated on the PCB. The boards were
softbaked at 90◦C for 2 minutes pre-exposure. The board was exposed to UV through
a mask and then developed in Microposit EC solvent 11 (procured from A-Gas
Multiplexed Biosensors for Drug Discovery Applications 106
Chapter 5
Electronic Materials) to remove the unexposed SU-8 from the board such that only
the reference pads were coated in SU-8. Post-exposure, the boards were baked at
90◦C for 2 minutes.
The PCBs were loaded immediately into the thermal evaporator and the
sensing pad was exposed through a shadow mask. The shadow mask was made from
a thin aluminium sheet (hundred micron thick). The deposition of tin oxide first,
followed by the spin coating of SU-8 was considered but the removal of the unexposed
SU-8 using the EC solvent would contaminate the sensing surface. The masks can
be cleaned and reused easily for several evaporations. The major drawbacks of this
technique is the pattern spreading near the edges of the holes, in form of a smooth
decay. This may be attributed to two effects. Firstly, the source of the vapours is not
a point source resulting in a penumbra region and secondly, the atoms scattering the
edges of the mask [155]. Since the features on the REFET PCB are large (several
milimeters) and there is sufficient distance between pads, the effect of spreading is
not significant. 10 nm of aluminium and 150 nm of tin oxide was deposited through
thermal evaporation. The boards were used without any further cleaning. The
ground pad was coated with silver paste and allowed to air dry.
s
Figure 5.1: PCB design for the REFET extended gate structure
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Figure 5.2: Manufactured PCB containing REFET extended gate structures
Dimension: 30 mm X 30 mm
Biofunctionalisation
The same process was followed for biofunctionalisation as the previous
chapters. GOPTS was heated to 120◦C and the PCB was exposed to the vapours
for 5 seconds through the shadow mask used for evaporation of aluminium and tin
oxide. This was done to prevent silanization of the reference and ground pads. The
boards were rinsed in DI water and dried. All pads were covered with teflon tape
leaving a circular interrogation area of 7.07 mm2 exposed. 2 µl of 156 µM peptide
solution was dispensed on to tin oxide coated pads and left to bind for 40 minutes.
The unreacted GOPTS sites were blocked by washing in 20% ethanol. The pads
were left in PBS pH 7.2 for 30 minutes to stabilise before conducting further tests.
Figure 5.3 shows the modified copper pads for biosensing.
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Figure 5.3: Modified copper pads for biosensing
Measurement Setup
The biosensors were interfaced with a commercially available MOSFET
array, ALD1106. This IC contains four n-channel enhancement mode matched
MOSFET transistors. The sensor pad and the reference pad were connected to the
gate terminal of two of the MOSFETs and the ground pad was connected to the
common ground of the measurement circuit.
Initially, the response of the MOSFETs to the phosphorylation reaction
was recorded for the tin oxide and SU-8 surfaces individually using the Agilent
B1500A HR CMU Semiconductor Device Analyser. The MOSFET has a low
threshold voltage of 700 mV and low gate leakage current of typically 0.1 pA. The
substrate bias was kept at 0 V for the entire measurement. The gate to source
voltage (VGS) was varied from 0-3 V while keeping the drain to source voltage
(VDS) at 1 V. The gate voltage was applied through a reference electrode and the
PCB was enclosed in a Faraday cage to minimise the effect of noise. The reaction
volumes were fixed to 50 µl. Figure 5.4 shows the schematic of the sensor setup.
The shifts in threshold voltage were observed.
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Figure 5.4: Schematic of sensor setup
In the second part of the study, the differential measurement between the
sensing and the reference pad was measured by an Arduino Uno. No reference
electrode was required in this study. The signal was amplified by an instrumentation
amplifier AD620 with a gain of 20. This IC was chosen for its low offset voltage,
high accuracy and low cost. The amplification stage was necessary because at the
next stage when the sensors were multiplexed, a small amount of the signal was lost
(40 mV attenuation).
The signal was then converted to a digital signal by the 10-bit analog-to-
digital converter present on the Arduino. The reference voltage for was set to 1.1 V
in order to bring the resolution down to 1 mV. The circuit was enclosed in a Farday
cage to minimise the effect of noise. The Arduino was powered by connecting it
to the USB port of a PC and the other ICs on the board were powered through
the Arduino. The VGS and VDS values were fixed at 1 V for the duration of the
measurement and the drain current was measured over a fixed interval of time.
The four REFETs were finally multiplexed through an analog multiplexer
CD74HC4052. This IC has a low input resistance (7 Ω) and contains four channels
that can be selected through the ’address select’ lines. Data from each channel was
collected for 10 seconds at every 0.5 second interval. Figure 5.5 shows the schematic
of the measurement setup. In the final design the multiplexer may be replaced by
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one containing more channels on one chip but for the purpose of simplicity, they
are retained in the figure. The shift in drain current with time was calculated for
stability, pH sensitivity, temperature sensitivity and phosphorylation studies. The
reaction volumes were fixed to 200 µl. All measurements were performed on three
different PCBs containing four REFET structures each and the average values were
considered. The errors were calculated from the standard deviation of the data.
Figure 5.5: Schematic of measurement setup for the multiplexed biosensors. Image
source for Arduino: https://www.arduino.cc/
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5.3 Results and Discussion
Response of ALD1106
The pH sensitivity of tin oxide and SU-8 thin films were measured
individually as extended gates to ALD1106. The drain current vs gate voltage
characteristics are shown in Figure 5.6. The surfaces were incubated in PBS buffer
pH 7.2 for 30 minutes prior to the experiment. The pH sensitivity of the SU-8 thin
films was 5.2±1.1 mV/pH. The pH sensitivity of tin oxide was found to be
50.1±3.5 mV/pH. As expected, the SU-8 surface shows a low pH sensitivity while
the tin oxide has a higher sensitivity to pH. We can now move towards
phosphorylation studies on the ’sensitive’ and ’insensitive’ surface.
Figure 5.7 shows the drain current versus gate voltage characteristics for
stability studies on the tin oxide thin films were performed after the
immobilisation of peptide. The surface was left in PBS buffer pH 7.2 for 30
minutes. The voltage shift over 10 minutes was 2.5 mV. The surface was stable for
conducting phosphorylation studies.
Figure 5.6: Left: pH sensitivity studies on tin oxide measured with ALD1106 Right:
pH sensitivity studies on SU-8 measured through ALD1106
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Figure 5.7: Left: Stability studies on tin oxide surface with immobilised peptide
measured through ALD1106 Right: Stability studies on SU-8 surface measured
through ALD1106
The voltage shifts for the phosphorylation studies on the tin oxide and SU-
8 surface are shown in Figure 5.8. The error bars represent the variation over three
different PCBs where all four of the pads have been used for measurement. The I-V
curves were first measured in PBS buffer pH 7.2 to determine the baseline. Each of
the measurements were conducted after 13 minutes of incubation in the measuring
solution. The SU-8 surface was incubated with inhibitor in PBS buffer pH 7.2 for
13 minutes prior to the experiment to block the surface and prevent false signals.
The control reaction was conducted with 1 µM ATP and 2.5 µl PKC lipid
activator. An average shift of 7 mV from the baseline was observed for the tin oxide
surface and a similar shift of 5 mV from the baseline was observed for the SU-8
surface. On addition of the kinase inhibitor along with PKC-α enzyme, the signal
shifted by an average of 8 mV for tin oxide and 7 mV for SU-8 from the baseline.
The phosphorylation reaction was conducted in the presence of ATP, activator and
enzyme. The voltage shift for the tin oxide surface was 48 mV and for the SU-8
surface was only 5 mV. Table 5.1 shows the voltage shifts for the phosphorylation
studies.
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The results were similar to what was expected. The active surface, tin
oxide, produced a large signal for the phosphorylation reaction while the passive
surface, SU-8, remained insensitive to all the reactions conducted in this study. The
system was compatible with the commercial CMOS IC used for measurement. These
form the building blocks of the REFET system described in the next subsection.
Figure 5.8: Voltage shifts for phosphorylation studies on tin oxide and SU-8
measured by ALD1106
Thin Film Control(mV) Inhibition(mV) Phosphorylation(mV)
Tin Oxide 7 8 48
SU-8 5 7 5
Table 5.1: Voltage shifts for phosphorylation studies on tin oxide and SU-8 measured
through ALD1106
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Response of REFET
The stability of the REFET was measured individually for the tin oxide
thin film and SU-8 thin film with ground connection as a reference. The results of
ten minutes of the study is shown in Figure 5.9 (Left). The surfaces were incubated
in PBS buffer pH 7.2 for 30 minutes prior to the study. The stability was measured
over 10 minutes with 30 second intervals. The average difference in drain current
values between the two surfaces is 0.6 µA over 10 minutes. 1 µA shift in drain
current on the transfer characteristics of ALD1106 corresponds to 10 mV shift in
drain current. Usually, a stable surface is expected to have a voltage shift below 10
mV in 10 minutes. Therefore, 0.6 µA shift in drain current is considered stable.
Figure 5.9 (Right) shows the drain current variations over 10 seconds for
pH sensitivity studies. The extended gates were incubated in PBS buffer pH 7.2
for thirty minutes prior to the study. The difference in drain current between the
tin oxide and SU-8 surface is measured. A pH sensitivity of 22.9±4.3 µA/pH was
achieved in this study.
Figure 5.9: Left: Stability studies on the REFET. Right: pH sensitivity studies on
the REFET
Figure 5.10 shows the drain current shifts of temperature sensitivity
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studies on the REFET. The extended gates were incubated at PBS buffer pH 7.2
at room temperature for 30 minutes prior to the experiments. The temperature of
the buffer was varied from 0-50◦C in 5◦C intervals. PBS buffer at 0◦C was heated
slowly in a temperature controlled water bath. THe temperature of the buffer was
monitored closely using a thermometer immersed in the solution. For each 5◦C
increment, the buffer was dispensed on the sensor surface and the measurements
were taken immediately. The measurements were taken over ten seconds for each
interval and measured over three boards where the four sets of pads were
multiplexed. The temperature sensitivity of 1.1 µA/◦C. The REFET structures do
not exhibit a significant temperature sensitivity. The variations due to
temperature possibly appear as a common mode signal between the two transistors
and does not appear in the differential measurements.
Figure 5.10: Drain current shifts with temperature on the REFET
The results for the phosphorylation studies on the tin oxide and SU-8
surface are shown in Figure 5.8. The error bars represent the variation in values
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over three different PCBs where sets of four of pads have been used for measurement
through the multiplexer. The difference in drain current was first measured in PBS
pH 7.2 for 10 seconds to determine the baseline. Each of the measurements were
conducted after 13 minutes of incubation in the measuring solution, similar to the
protocols in the previous chapters. The SU-8 surface was incubated with inhibitor
in PBS buffer pH 7.2 for 13 minutes prior to the experiment to block the surface
and prevent false signals due to interaction of inhibitor with the thin film.
The control reaction was conducted with 1 µM ATP and 2.5 µl PKC lipid
activator. An average difference in drain current of 3.9 µA was observed between
the SU-8 and the tin oxide surfaces. On addition of the kinase inhibitor along with
PKC-α enzyme, the average difference in drain current remained close to the control
signal at 6.0 µA. The phosphorylation reaction was conducted in the presence of
ATP, activator and enzyme. The average difference in drain current was measured
to be 23.4 µA. The effective phosphorylation signal measured was 19.5 µA.
Figure 5.11: Left: Shift in drain current versus time for phosphorylation studies on
the REFET. Right: Drain current shifts due to phosphorylation
While the phosphorylation signal is significantly higher than the control
and inhibition signal, a more stable result would be desirable. The instability in
the readings may be due to a number of reasons. Firstly, the ground connection
might not be at a stable voltage. Secondly, there might be other sources of noise
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in the circuit arising from the connections. Thirdly, the instabilities may be due to
the fact that the extended gates are at a floating potential. Further investigation
is required to determine the true cause of the instability and steps can be taken to
reduce it. Different inhibitors have not been tested on the REFET as a part of this
study. This system can be considered to be proof of concept for screening protein
kinase inhibitors.
5.4 Conclusion
In this chapter the initial stages of developing a REFET structure for
multiplexed screening of protein kinase inhibitors is described. A PCB with three
copper pads that were able to fit under the well of a 96 well plate was designed.
Building from the previous chapter, the sensing and reference layers were deposited
on to the PCB. The REFET structure was interfaced with a commercial CMOS IC
for measurement.
The initial measurements were conducting by connected the thin films
individually to the CMOS IC. The results were comparable to that in the previous
chapters. The REFET structure was assembled in the next part of the study and
the sensors were multiplexed for the measurement. The results are promising but
the fluctuations need more investigation in the future for further development of
the device. Presently, the device works as a proof of concept and can form a base
platform for screening other kinase inhibitors.
There are a few limitations of this study. Firstly, the manual polishing of
the board is not very practical when the 96 sets of sensors are fabricated.
Secondly, the blocking of the surface with the inhibitor needs to be replaced by a
more efficient method of producing an ’insensitive’ surface. When different
inhibitors are considered, they might interact differently with the surface
depending on their chemical composition and this method may not be successful.
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Also, this adds an extra step to the processing of the board and requires one to
know exactly which wells are going to be used for the inhibition reaction. The
measuring circuitry is very easy to construct from commercially available
integrated circuits but in the future, designing monolithic integration may be
considered to bring the cost down for mass production.





There is a pressing need in today’s world for faster and more cost
effective drug discovery systems. This has led to the widespread popularity of HTS
methods for screening new compounds. Protein kinase inhibitors have emerged as
a major class of drugs which target several diseases caused by abnormal protein
phosphorylation. This research aims at developing a HTS method to screen
kinases both time and cost effectively. Unlike the assays currently used by the
pharmaceutical industries, which rely heavily on the presence of antibodies and
radio tags, this biosensor platform depends on the simple concept of detecting pH
changes due to phosphorylation.
This thesis was aimed towards developing a biosensor compatible with a 96
well microtitre plate for screening of protein kinase inhibitors. The REFET device
structure appeared very promising as it would allow the elimination of the reference
electrode. In the initial part of this study, pH sensitive silicon nitride was interfaced
with a PCB to act as a biosensor. While this method showed some promising
results, it had some practical limitations in constructing the sensor array. Firstly,
the process to mounting the wafers on the PCB was by attaching them manually
with silver conductive paste. This process may prove to be too cumbersome when
there are 96 sensors instead of the four on the test board. Also, when silver paste is
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completely dry, it is a poor adhesive so the shelf life of these sensors would only be
a few hours long.
OTFTs were considered for this application in the next part of this study.
The devices themselves were very promising by virtue of their small size and the
ability to include both extended gates and FETs on the same chip for a reasonable
price. However, the stability of the batch of devices under test was poor and could
not provide reliable results for the phosphorylation studies. These devices may
be explored in the future for this application if a batch of devices with improved
stability can be acquired.
Tin oxide as sensing layer, deposited directly on to a PCB formed the next
part if the study. Though a stable surface with a good pH response was achieved,
the phosphorylation signals were greatly amplified. In an attempt to troubleshoot
the device, the PCB was polished prior to the deposition of tin oxide. The signals
from the phosphorylation, inhibition and control reaction signals improved by this
process. The PCBs were polished manually for this thesis but when the full array
needs to be polished, a mechanised process with consistent results will need to be
implemented. This study formed the first part of developing the REFET biosensor.
For developing the reference FET, 115 nm of SU-8 proved to be the most
successful in producing a noise free signal with sufficient signal strength among the
different processes that were tried. The signal due to the reaction of the inhibitor
with the SU-8 surface is suppressed by blocking the SU-8 thin films with inhibitor
prior to the phosphorylation studies being performed. This might not be the best
approach to producing an insensitive surface but due to time restrictions we did
not wasn’t further investigate other methods. The pH sensitivity and signals due
to phosphorylation studies were low enough to consider the SU-8 thin film as a
reference sensor for the final REFET design.
Finally, the SU-8 and tin oxide thin films were interfaced with commercial
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MOSFET ICs. The signal levels were similar to previous studies. The extended gates
for the REFET structure was fabricated on a PCB. The devices were multiplexed
for measurement. This allowed the elimination of the reference electrode from the
device setup. While some reasonable differences in drain current were measured,
there were fluctuations in the measured signal with time.
The integration of the sensing layer on the FR4 substrate with
commercially available integrated circuits facilitated the designing of a low cost,
simple system for screening protein kinase inhibitors. The present system was only
tested for its capability to provide ’yes’ and ’no’ answers to the drug activity of the
kinase inhibitor under test. The data collection can be made faster by measuring
over a smaller duration. The fast switching times of the multiplexer will further
aid the speed of this screening test.
Research questions in our aim were addressed. The material for the pH
sensitive sensor was selected to be tin oxide. The insensitive surface was constructed
with SU-8 with its surface blocked with inhibitor. The field effect device structure
chosen was the REFET for differential measurement without a reference electrode.
Finally, the sensors were interfaced with integrated circuits.
6.2 Outlook
This system for drug discovery is still in early phases of development. One
of the major avenues that can be explored is to test the device using different kinase
inhibitors and potentially try to quantify the extent of inhibition that each drug
provides. In order to do this study, it will be necessary to develop a more accurate
method of collecting data from the REFET structure. An analog-to-digital converter
of a higher resolution is required and the ground connection should provide a more
stable voltage.
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A better method for the fabrication of the pH insensitive surface needs
to be developed. The blocking of the surface with inhibitor is not a very effective
method because different inhibitors may interact differently with the surface. Other
polymers or post processing of SU-8 might be more effective.
One can decide to move away from the 96 well plate and design a more
compact sensor array of a smaller size. In this thesis, commercial ICs have been used
to keep the cost low but integration of matched pair MOSFETs, microcontrollers
and multiplexers can be considered. Addition of a digital readout system can make
the system independent of computers for displaying data.
Finally, the device features can be expanded by integration of a
microfluidics module to make up a new sample delivery system for the device to
replace the existing liquid handling systems used for 96 well plates. The
measurement circuit can be made smaller and more compact by designing an
integrated circuit consisting of multiplexers, analog-to-digital converter and
processor. A display system can also be added to ensure better portability of the
device.
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Figure 6.1: Ideas on future implementation
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[73] Schöning MJ et al. “Miniaturised Flow-Through Cell with Integrated
Capacitive EIS Sensor Fabricated at Wafer Level Using Si and SU-8
Technologies”. Sensors and Actuators B: Chemical 108 (2005), pp. 986–992.
[74] Bhalla N et al. “Protein Phosphorylation Analysis Based on Proton Release
Detection: Potential Tools for Drug Discovery”. Biosensors and
Bioelectronics 54 (2014), pp. 109–114.
[75] Bergveld P. “Thirty Years of ISFETOLOGY: What Happened in the Past 30
Years and What May Happen in the Next 30 Years”. Sensors and Actuators
B: Chemical 88.1 (2003), pp. 1–20.
[76] Pachauri V. and Ingebrandt S. “Biologically Sensitive Field-Effect
Transistors: From ISFETs to NanoFETs”. Essays in Biochemistry 60
(2016), pp. 81–90.
[77] Lee C, Kim SK, and Kim M. “Ion-Sensitive Field-Effect Transistor for
Biological Sensing”. Sensors 9 (2009), pp. 7111–7131.
[78] Dzyadevych SV et al. “Enzyme Biosensors Based on Ion-Selective Field-Effect
Transistors”. Analytica Chimica Acta 568 (2006), pp. 248–258.
Multiplexed Biosensors for Drug Discovery Applications 132
References
[79] Veigas B, Fortunato E, and Baptista PV. “Field Effect Sensors for Nucleic
Acid Detection: Recent Advances and Future Perspectives”. Sensors 15
(2015), pp. 10380–10398.
[80] Freeman R, Gill R, and Willner I. “Following a Protein Kinase Activity
Using a Field-Effect Transistor Device”. Chemical Communications (33
2007), pp. 3450–3452.
[81] Li J, Sun Z, and Feng Y. “Solution Processable Low-Voltage Organic Thin
Film Transistors with High-k Relaxor Ferroelectric Polymer as Gate
Insulator”. Advanced Materials 24.1 (2012), pp. 88–93.
[82] Arias AC et al. “Materials and Applications for Large Area Electronics:
Solution-Based Approaches”. Chemical Reviews 1 (2010), pp. 3–24.
[83] Reese C et al. “Organic thin film transistors”. Materials Today 7 (2004),
pp. 20–27.
[84] Sokolov AN, Mark E. Roberts, and Zhenan Bao. “Fabrication of low-cost
electronic biosensors”. Materials Today 12 (2009), pp. 12–20.
[85] Han CY et al. “A Study on Pentacene Organic Thin-Film Transistor With
Different Gate Materials on Various Substrates”. IEEE Electron Device
Letters 6 (2017), pp. 744–747.
[86] Tang ML. et al. “Ambipolar, High Performance, Acene-Based Organic Thin
Film Transistors”. Journal of the American Chemical Society 19 (2008),
pp. 6064–6065.
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A.0.1 Thermal Evaporation of Tin Oxide and Aluminium
1. Clean PCBs by sonication in acetone and isopropanol for 5 minutes each, dry
using N2 or compressed air.
2. Polish PCBs with electrode polishing pads coated in 5 µm alumina slurry
3. Sonicate in acetone and isopropanol for 5 minutes each to remove any residues,
dry using N2 or compressed air
4. Mask contacts with kapton tape or shadow mask
5. Load onto vacuum evaporator
6. Load aluminium piece on a titanium boat
7. Load tin oxide in an alumina coated wire basket
8. Pump system until the vacuum reaches 2X10−6 Torr
9. Set the substrate rotation motor to a supply of 2 V
10. Evaporate at a rate of 0.3 nm/s
11. Proceed without any further cleaning of the PCBs once unloaded
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A.0.2 Protocol for Immobilisation of Peptide on Si3N4
surfaces
1. Immerse the clean sensor surface in 98% GOPTS for 45 minutes or heat
GOPTS in a beaker to 120◦C and hold the thin film surfaces close to the
vapours for five seconds
2. Wash with de-ionised water thoroughly to remove excess silane, dry with N2
gun
3. Drop 2 µl of the peptide solution on to the dry surface and leave to bind for
40 minutes
4. Wash with 20% ethanol to block the unreacted GOPTS sites
5. Store in PBS for further studies
A.0.3 PDMS Membrane Preparation Protocol
1. Mix PDMS base and curing agent in the ratio 10:1 by weight
2. Degas the mixture for 20 minutes in a desiccator
3. Pour the PDMS on the mould
4. Place the PDMS coated mould in an oven at 90◦C for 30 minutes
5. Release the membrane from the mould
A.0.4 Protocol for SU-8 spin coating
1. Clean PCBs by sonication in acetone and isopropanol for 5 minutes each, dry
using N2 or compressed air.
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2. Polish PCBs with electrode polishing pads coated in 5 µm alumina slurry
3. Sonicate in acetone and isopropanol for 5 minutes each to remove any residues,
dry using N2 or compressed air
4. Cover contacts with teflon tape
5. Load in spin coater
6. Start the vacuum pump to secure the PCB
7. Dispense SU-8 on the substrate
8. Spin at 500 rpm for 30 seconds to spread the SU-8
9. Spin at 1000 rpm for 60 seconds
10. Remove PCB from spin coater, soft-bake at 90◦C for 2 minutes
11. Expose SU-8 to UV through a mask aligner
12. Post exposure bake at 90◦C for 2 minutes
13. Develop by immersing in Microposit EC Solvent 11
14. Wash with isopropanol thoroughly to remove residues of undeveloped SU-8
15. Use without further cleaning





B.0.2 Design of the microfluidics module
A number of different designs and approaches were adopted to explore the
methods to construct a mould for a microfluidic cell. This cell will eventually aid
in the delivery of samples to the final sensor array. PDMS will be poured on the
mould to replicate the design after which it will be irreversibly bonded to a glass
slide or silicon wafer containing the sensors. To acknowledge the importance of
repeat measurements to validate results and ensure the reproducibility of the sensor
system, the microfluidic mould is envisioned to contain different wells where the
same liquid will flow. Here, we explore a 3-well based system through simulation.
The construction of a two well based system is attempted using 3D printing and
laser cutting technologies.
B.0.3 Materials and Methods
A number of possible designs for the microfluidics cell was explored. The
fluid flow through different cell designs were first simulated using COMSOL
Multiphysics 5.1. The cell designs were constructed using AutoCAD 2015 and then
exported to COMSOL for further studies. With the view of simplicity and to save
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time, the simulations were performed in two dimensions instead of three. A
laminar flow was assumed for all the tests. For the purpose of 3D printing, the
designs were further simplified.
B.0.4 Results and Discussion
Initially, a design with three wells and three channels of equal width was
designed. Assuming a flow rate of 2 µl/min at the inlet, with channels of dimension
350 µm each, feeding circular wells of 5 mm diameter, the simulation was performed
to display the steady state for 1 second. Figure B.1 shows the surface velocity profile
of the cell and it is quite clear that the velocity in the middle channel is higher than
the other two channels.
Figure B.1: Surface velocity profile of circular wells with channels of equal thickness
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Figure B.2: Surface velocity profile for circular wells with adjusted channel thickness
Next, it was investigated through simulation to find out how wide the
middle channel needs to be in order to ensure the same flow rate in each of the
channels. The results revealed that the middle channel needs to be constricted
to 213 µm for this condition, as illustrated in Figure B.2. Finally, the wells were
changed from circular to elliptical (major axis=5 mm, minor axis=3 mm). The
simulation results are shown in Figure B.3.
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Figure B.3: Surface velocity profile for elliptical wells with adjusted channel
thickness
The design was further simplified to evaluate its ability to be 3D printed
and laser cut. The two well design is shown in Figure B.4. The channel width was
1 mm and length of 500 microns. The elliptical wells had a major axis of 3 mm and
a minor axis of 5mm. This design was laser cut on a perspex sheet and is shown
in Figure B.5. 3D printing was also attempted using ABS plastic and is shown in
Figure B.6.
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Figure B.4: AutoCAD design for microfluidic mould
Figure B.5: Laser cut microfluidic mould
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Figure B.6: 3D printed microfluidic module
The attempts were unsuccessful for a number of reasons. The MakerBot
3D printer did not have the required resolution to reproduce the dimensions of
the design. The laser cutting of perspex sheets was comparatively better but the
surface of the finished product was too rough to be used as a PDMS mould. To
make the surface smooth, chloroform was rubbed on the finished product but proper
smoothness was not achieved as shown in Figure B.5. The best result was obtained
from the stereolithography (SLA), printer shown in Figure B.5 When this was used
as a mould, the PDMS replicated the undulations on the surface and hence did not
form a proper bond to the glass surface.




C.0.1 IC pin diagrams
Figure C.1: Pin diagrams of ICs used in the study [Image source: component data
sheet]
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C.0.2 Essential Features of ICs
ALD1106
• Low gate leakage 0.1 pA typically, 10 pA maximum
• Low threshold voltage 700 mV
• High input impedance of 1014 Ω
• Off drain current 10 pA typically, 400 pA maximum
• Mismatch 0.5%
AD620
• Gain set with single external resistor
• Low noise 0.28 µV noise p-p between 0.1 Hz and 10 Hz
• Low power, 1.3 mA maximum current supply
• Common mode rejection ration 110 dB at gain 10
CD74HC4052
• Low on resistance of 7 Ω
• Low crosstalk between channels
• Break-before-make switching
• Maximum switch turn-on delay 65 ns
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